Modulation of Drug Metabolism by Food Restiction by Su, Paul Kupen
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
Doctoral Dissertations Graduate School
11-1985
Modulation of Drug Metabolism by Food
Restiction
Paul Kupen Su
University of Tennessee, Knoxville
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research and Creative Exchange. It has been
accepted for inclusion in Doctoral Dissertations by an authorized administrator of Trace: Tennessee Research and Creative Exchange. For more
information, please contact trace@utk.edu.
Recommended Citation
Su, Paul Kupen, "Modulation of Drug Metabolism by Food Restiction. " PhD diss., University of Tennessee, 1985.
https://trace.tennessee.edu/utk_graddiss/3785
To the Graduate Council:
I am submitting herewith a dissertation written by Paul Kupen Su entitled "Modulation of Drug
Metabolism by Food Restiction." I have examined the final electronic copy of this dissertation for form
and content and recommend that it be accepted in partial fulfillment of the requirements for the degree
of Doctor of Philosophy, with a major in Human Ecology.
Dileep S. Sachan, Major Professor
We have read this dissertation and recommend its acceptance:
Frances Ann Draughon, Hugh O. Jaynes, Roy E. Beauchene
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)
To the Graduate Council: 
I am submitting herewith a dissertation written by Paul Kupen Su 
entitled 11Modulation of Drug Metabolism by Food Restriction. 11 I have 
examined the final copy of this dissertation for form and content and 
recommend that it be accepted in partial fulfillment for the 
requirements of the degree of Doctor of Philosophy, with a major in 
Human Ecology. 
We have read this dissertation 
and recommend its acceptance: 
Accepted for the Council: 
Vice Provost 
and Dean of The Graduate School 
MODULATION OF DRUG METABOLISM BY FOOD RESTRICTION 
A Dissertation 
Presented for the 
Doctor of Philosophy 
Degree 
The University of Tennessee, Knoxville 
Paul Kupen Su 
December 1985 
ACKNOWLEDGEMENTS 
The author wishes to express his sincere thanks and 
appreciation to Dr. Dileep S. Sachan, major professor and chairman of 
his dissertation committee, for his time spent counseling, advising 
and assisting in the preparation of this manuscript and for his 
support and encouragement throughout the program of study. Special 
thanks and appreciation is offered to Dr. Roy E. Beauchene, Dr. 
Frances A. Draughon and Dr. Hugh 0. Jaynes for their counsel and 
support and for serving on his dissertation committee, to Dr. Fred 
Applehans for his assistance and use of analytical equipment and to 
Dr. William Sanders for his assistance in the statistical analysis 
of the data. 
The author is grateful to Dr. Betty R. Carruth, Head of the 
Department of Nutrition and Food Sciences, and faculty of the 
department for their help throughout the program of study. 
Special thanks are offered to Robert Berger, Wanda Dodson, 
George Loo, Robin Ruark, Becky Smith, Tae Hyong Rhew and other 
graduate students in the department for their assistance and 
friendship and to Dr. David Shannon, S. L. Panter and E. Peck for 
their constant help and encouragement. 
Thanks are extended to Mike Aaron, Leslie Cobb, and the 
secretaries for their help and friendship. 
The author wishes to express special appreciation to his 
mother, father, sisters and brothers for their support, encouragement 
and other assistance which make the efforts put forth in this program 
of study worthwhile. 
i i 
ABSTRACT 
The effects of the level and duration of feed restriction on the in 
vitro activities of hepatic drug metabolizing enzyme system were 
examined in male weanling Sprague Dawley rats fed ad libitum or feed 
restricted at 15%, 30% and 45% for a period of one to five weeks 
(Experiment I). Increasing levels and duration of feed restriction 
resulted in significant progressive increases in hepatic microsomal 
protein, cytochrome P-450 content and the in vitro activities of 
microsomal aniline hydroxylase. p-chloro-methly-aniline(PCMA)­
N-demethylase and p-nitrophenol UDP-glucuronyl transferase activities 
were unaltered by the feed restriction while cytochrome c reductase 
activity was significantly decreased. In addition, the in vitro 
activities of the hepatic NADPH-generating enzymes were also 
significantly increased with the increasing levels and duration of feed 
restriction. It is concluded that the drug metabolizing enzymes did not 
necessarily change in concert with the cytochrome P-450 content and 
that prolonged feed restriction in healthy animals resulted in enhanced 
drug metabolizing capacity. This enhancement in drug metabolizing 
capacity was progressive with the increasing levels and duration of 
feed restrition. The greatest enhancement was observed when the animals 
were restricted at 45% for 4 or 5 weeks. 
In two subsequent experiments, the in vivo metabolism of 
antipyrine and carbon tetrachloride toxicity were examined in rats feed 
restricted at 45% for four weeks. The feed restriction resulted in a 
i i i 
significant decrease in the blood half-life of antipyrine and 
increased morbidity due to carbon tetrachloride. Thus feed restriction 
resulted in increased in vivo metabolism of xenobiotics and 45% feed 
restriction for four weeks was sufficient to cause a significant 
increase. These results supported the changes observed in the in vitro 
activities of the drug metabolizing system. 
iv 
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CHAPTER I 
INTRODUCTION 
Food restriction has become increasingly important not only 
for those with limited food supply in certain underdeveloped regions 
of the world but also for those in the affluent society for cosmetic 
as well as health reasons. The modification of diet has long been 
known to affect drug metabolism and the drug metabolizing enzyme 
(DME) system (1-16). This is of great significance because we are 
constantly exposed to a great amount of drugs and chemicals in our 
environment. Dietary modifications that can affect drug metabolism 
include a deficiency or lack of certain individual nutrients, or all 
nutrients as in starvation and food restriction. 
1 
Protein deficiency has been shown to decrease hepatic 
cytochrome P-450-dependent mixed-function oxidase (MFO) activity and 
increase the duration of the action of barbiturates by decreasing 
their rates of metabolism and tissue clearance in male rats (1). In a 
study of Asian lactovegetarians with low protein intakes, a reduced 
antipyrine clearance was reported (2). A low carbohydrate intake also 
has been reported to decrease hepatic cytochrome P-450 content and 
aminopyrine demethylase activity (3). Deficiency of polyunsaturated 
fatty acids has been shown to depress the capacity of the MFO system 
for induction (4) and a decrease in essential fatty acids in diets 
resulted in depressed basal MFO activities (5). A dietary deficiency 
of vitamin C in guinea pigs has been found to result in decreased MFO 
activities and their induction by organochlorine pesticides (6). 
2 
These are just some of the many studies on the deficiency of single 
nutrients. 
A restriction of all nutrients such as encountered during 
fasting is also known to influence drug metabolism. The effects are 
dependent upon a number of factors such as species, sex and strain of 
the animals, and also the type of drug substrate used to determine 
the activity of the OME (7). The general concensus is that starvation 
impairs drug metabolism in the liver of male rats (8, 9, 10) and mice 
(11). Kato and Gillette (10) reported an impaired drug metabolism in 
starved male rats but not in starved female rats. These differences 
between sexes in drug metabolism were attributed to the influence of 
androgens on the hydroxylation and N-demethylation systems (12). 
There are numerous studies on the effects of starvation on drug 
metabolism but few on the effect of prolonged food restriction 
(semi-starvation) which is an issue of concern for many rich and poor 
people around the world. 
Recently, it has been demonstrated that a 45-percent feed 
restriction for four weeks, unlike starvation, enhanced in vivo 
metabolism of hexobarbital and the in vitro activities of certain 
hepatic microsomal DME as well as the NADPH-generating enzymes in 
male rats (13, 14, 15). A 50-percent feed restriction for forty-nine 
days also increased the in vitro activities of biphenyl hydroxylase, 
4-methylumbelliferone-glucuronyl transferase, and p-nitrobenzoate 
(PNBA)-reductase as well as glucose-6-phosphate dehydrogenase (G6PD), 
6-phosphogluconate dehydrogenase (6PGD) and malic enzyme (ME) in the 
livers of male rats (16). These studies indicated that drug 
3 
metabolism and DME activities during prolonged food restriction is 
quite different from that caused by the deficiency of a single 
nutrient or by starvation. 
The main objective of the study was to determine the effects 
of different levels and duration of feed restriction on drug 
metabolism by: 
a. monitoring changes in the in vitro activities of the DME 
system in the liver; 
b. determining the in vivo metabolism of antipyrine under 
defined conditions of feed restriction; 
c. assessing the toxicity of carbon tetrachloride under 
defined conditions of feed restriction. 
CHAPTER I I 
REVIEW OF LITERATURE 
1. HEPATIC DRUG METABOLISM 
4 
It is well known that most drugs and environmental chemicals 
(xenobiotics) are metabolized primarily by the enzyme system located 
in the endoplasmic reticulum of the liver although the metabolism can 
also occur in the kidney, gastrointestinal tract, lung, gut flora, 
adrenal, brain, heart, muscle, skin, spleen and testes (17). The 
spherical membrane vesicles derived from the endoplasmic reticulum 
during homogenization of a tissue are called microsomes. These remain 
in the 10, 000 x g supernatant and can be sedimented by differential 
centrifugation at 105,000 x g for 1 hr. The microsomes contain the 
majority of the enzymes responsible for the metabolism of xenobiotics 
( 18). 
In general, xenobiotics are metabolized by the soluble, 
mitochondrial and the microsomal fractions. This usually involves 
oxidation, reduction, hydrolysis and conjugation. The metabolism 
takes place in two phases. Phase I involves oxidative 
biotransformation of the drug, which introduces new functional groups 
(hydroxyl, carboxyl, amino and sulphydryl) into the drug molecules. 
Phase II reactions are synthetic reactions and involve conjugations 
of the parent compound or its metabolite with an endogenous substrate 
(glucuronic acid, glycine etc.) (17). The net result of these two 
phases is the conversion of a lipophilic molecule into a more polar 
5 
and hydrophilic molecule and thus readily excretable in urine breath 
or sweat. 
The Phase I reactions metabolize xenobiotics as well as 
endogenous substrates such as steroids and fatty acids and are 
collectively termed "mixed function oxidases". These reactions are 
carried out by a membrane-bound enzyme system which involves at least 
two electron transport chains. One contains a hemoprotein, cytochrome 
P-450 and a flavoprotein, reduced nicotinamide adenine dinucleotide 
(NADPH) cytochrome c reductase. The other is comprised of the flavin 
enzyme NA DH cytochrome b5 reductase and a heme protein cytochrome b5 
(17, 19, 20). The main events of the cytochrome P-450 mediated drug 
oxidation scheme are illustrated in Figure 1 and briefly described as 
follows: 
The ferric heme iron cytochrome P-450 (P450.Fe3
+
) first 
reacts with the drug substrate (RH) to form a complex (P450.Fe3
+
.RH). 
This complex then undergoes reduction to a ferrous heme iron 
cytochrome P-450 - substrate complex (P450.Fe2+.RH) by the electron 
transfered from NADPH by cytochrome c reductase. The reduced complex 
(P450.Fe2+.RH) then reacts with oxygen to form an oxycytochrome P-450 
complex (P450.Fe2+.o
2
.RH) which may further undergo reduction to form 
a peroxide anion intermediate with a ferric heme iron cytochrome 
P-450. The second electron may originate from NADH via cytochrome b5 
reductase and cytochrome b5. The intermediate then further 
dissociates to form the oxidized substrate, oxidized cytochrome P-450 
and a molecule of water. 
NADH � cytochrome b5 reductase �cytochrome b5 
2:
50
e
7 
Ot�  ;e
2+. RH 
/ 02 
P450 
?+ Fe- • RH 
/ 
NADPH� cytochrome c reductase -} 
P450 
F 3
+ 
e 
.. 
I 2-02 
RH] 
+ 2H 
\�ROH 
� 
P450 
Fe3
+ 
P450 
�
RH 
Fe3+ .. RH 
Figure 1. Proposed scheme of microsomal drug oxidation adapted from Wolf (19). RH = substrate 
e = electron; P450 Fe = heme iron of cytochrome P-450; o2 = oxygen. 
0) 
The oxidative reactions catalyzed by cytochrome P-450 are 
many and include aliphatic hydroxylation, aromatic hydroxylation, 
epoxidation, N-dealkylation, 0-dealkylation, S-dealkylation, 
sulfoxidation, deamination as well as desulfuration (17, 19, 20). A 
brief summary of the main reactions encountered are as follows: 
a) aliphatic hydroxylation--oxidation of aliphatic 
hydrocarbons producing alcohols. e. g. n-Butane. 
7 
b) aromatic hydroxylation, epoxidation--oxidation of aromatic 
hydrocarbons predominantly yielding phenols. e. g. Bromobenzene. 
6 ----� c5 Br ?¢ 
� � 
VoH 
c) aliphatic epoxidation--oxidation of unsaturated 
hydrocarbons yielding epoxides. e. g. Aflatoxin s1• 
----;>- 0 
0 0 0 
8 
d) N-dealkylation--N-demethylation of secondary and tertiary 
amines yielding either primary or secondary amines together with an 
aldehyde. e. g. Aminopyrine. 
O
y
N,
{
H3 
CH - N l==l. CH 3 I 3 
CH3 
-------� 
+ HCHO 
e) O-dealkylation--0-demethylation or deethylation of ethers 
producing alcohols of phenols and formaldehyde or acetaldehyde 
respectively. e. g. Phenacetin. 
CH3CHO 
f) S-dealkylation--S-demethylation of thioethers--not usually 
mediated by cytochrome P-450. e. g. 6-Methylthiopurine. 
SCH3 N N�·� 
��N/ 
The Phase II reactions generally include synthetic reactions. 
It involves the coupling of the xenobiotics containing the hydroxyl, 
carboxyl, amino and sulfhydryl groups or their Phase I metabolites to 
an endogenous molecule such as glucuronic acid, sulfate, glutathione, 
glycine or other amino acids. This results in a more polar and 
excretable product (20). The major drug conjugation pathways are: 
glucuronic acid conjugation, sulfate conjugation, amide synthesis, 
9 
mercapturic acid synthesis, methylation, conjugation of substrate 
analogs and glucoside conjugation (18). In general, both oxidation 
and conjugation reactions may result in the termination of 
pharmacologic activity (inactivation) of a xenobiotic, however, there 
are many instances where the product is more toxic than the parent 
compound. Therefore, the same enzyme system that protects the 
organism from the harmful effects of certain toxic xenobiotics can 
also activate a biologically inert compound to a toxic product. The 
drug metabolizing system is influenced by a number of factors such as 
sex (10), species (30) age (31) and environmental factors. Among the 
latter, vegetables belonging to the Brassica genus such as Brussels 
sprouts, cabbage (22, 23), charcoal broiled meats (24, 25), cigarette 
smoke (26, 27), soft wood bedding (28, 29) and a variety of drugs 
metabolized by the mixed function oxidase system are also known to 
modify the drug metabolizing enzymes. Among these, the nutritional 
factors are of immediate interest here. 
2. EFFECT OF DIETARY PROTEIN DEFICIENCY 
Theoretically, a deficiency of dietary protein could result 
in a) catabolism of tissue protein, reducing the amount of amino 
acids available for protein synthesis which in turn reduces the 
amount of drug-metabolizing enzymes, and b) competition between the 
metabolism of drugs and the need of the tissues for the substrates 
used for conjugation of drugs (glucuronide, sulphate, glycine, etc.) 
as nutrients (32). In 1973, Mgbodile et al. (33) demonstrated that 
the consumption of protein-deficient diets resulted in lower cell 
10 
numbers in the liver as reflected by decreased DNA content and less 
microsomal protein per gram of liver. Decreased activities of hepatic 
microsomal enzymes specific for pentobarbital, strychnine, 
zoxazolamine and aminopyrine were observed when weanling rats were 
fed either a protein-deficient diet (5% and 10% protein) for two 
weeks or a protein-free diet for four days (34). Hayes and Campbell 
(35), in feeding rats 5% and 20% protein diets for 14 days, reported 
that the hepatic cytochrome P-450 content (0. 16.::, 0.03 vs 0. 41.::, 0. 07 
nmoles/mg protein), ethyl morphine N-demethylase, (400.::, 48 vs 1200 + 
70 nmoles HCHO produced/hr/mg protein) and aniline hydroxylase (8.6 + 
1. 2 vs 23. 8.::, 1. 8 nmoles p-aminophenol/hr/mg protein) activities were 
to be decreased in rats fed the low protein diet. They further 
demonstrated that the protein deficiency also impaired the 
inducibility of these enzymes. Their observations are in agreement 
with those of Marshall and McLean (36) who reported that the 
activities of mixed function oxidase system were related to dietary 
protein intake. Recently, Kawano and Hiraga (37), in feeding rats a 
protein-free diet for four to 67 days, reported that the decrease in 
the drug-metabolizing enzymes were biphasic (decreasing rapidly 
during the first three-week phase and then at a much slower rate) and 
that the inducibility of the enzymes was diminished with increased 
severity of protein depletion. The activity of glucuronyltransferase, 
however, was reported to be increased in protein-deficient rats (38). 
The compounds, such as carbon tetrachloride (39) and heptachlor (40), 
which are activated by microsomal metabolism, were found to be less 
toxic in rats fed diets low in proteins. The effect of protein 
11 
deficiency, therefore, does not necessarily translate into increased 
toxic effects of all foreign compounds. 
3. EFFECT OF DIETARY LIPIDS DEFICIENCY 
Since most of the drug-metabolizing enzymes are located in 
membrane structures, the metabolic fate of xenobiotics is also 
influenced by the permeability of the subcellular membranes to these 
compounds. The requirement of lipids for proper function of the 
enzymes bound to those membranes is well established (4, 32, 41, 42). 
Kamataki and Kitagawa (42) reported a decrease in hepatic 
drug-metabolizing enzymes when the microsomes were subjected to 
peroxidation. Strobel et al. (32) reported that phosphatidylcholine 
appears to be essential for the NADPH-dependent reduction of 
cytochrome P-450 and drug hydroxylation. Di Augustine and Fouts (41) 
further suggested that fatty acids must be incorporated into the 
membrane phospholipids to be functional since the addition of 
unsaturated fatty acids to an incubation mixture resulted in 
inhibition of the drug metabolizing enzymes. 
The role of the degree of saturation of dietary lipids has 
also been extensively studied. The effect of saturated fatty acids on 
drug metabolism was dependent on the absolute amount of fat rather 
than the chain length. An increase in the saturated fatty acid 
content in the diet from 15% to 35% resulted in a substantial 
increase in aniline hydroxylase activity (43). However, unsaturated 
fatty acids are found to be more important in promoting the mixed 
function oxidase activity (44). This is in agreement with the 
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findings of Norred and Wade (45), who later reported that a diet 
containing unsaturated fatty acids (3% corn oil) better supported the 
phenobarbital induction of hexobarbital oxidase and aniline 
hydroxylase than a similar diet containing saturated fatty acids (3% 
coconut oil). In 19 78, Hietanen et al. (46) suggested that dietary 
cholesterol may be essential in maintaining the activities of certain 
drug-metabolizing enzymes such as p-nitroanisole 0-demethylase, 
ethoxycoumarin 0-deethylase, and UDP-glucuronyltransferase, but not 
cytochrome P-450 content. In a later study, they reported that the 
cytochrome P-450 content, diphenyloxazole hydroxylase and 
ethoxycoumarin 0-deethylase activities were all increased about 
twofold in the livers of their rats that were fed a 2% cholesterol 
diet, as compared to those fed a cholesterol-free diet (47). The 
hepatic epoxide hydrolase activity was increased about threefold, 
while the hepatic UDP-glucuronyltransferase activity was increased 
1. 5-fold in the rats fed the 2% cholesterol diet. The cholesterol-fed 
rats exhibited greater phenobarbital inducibility of the 
drug-metabolizing enzymes (47). They concluded that 2% dietary 
cholesterol for four weeks has potent effects on the structure of 
endoplasmic reticulum in the liver, and is able to alter the response 
of drug-metabolizing enzymes in the membrane. Thus, ·a dietary lipid 
deficiency, especially in the form of unsaturated fatty acids, can be 
expected to result in a decrease in the metabolism of drugs and 
foreign compounds. This premise is in agreement with the findings of 
Norred and Wade (48), who reported that rats fed a synthetic fat-free 
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diet had a significantly lower cytochrome P-450 content, when 
compared with the controls. 
Therefore, certain dietary lipids are required for the normal 
synthesis of the mixed-function oxidase components and for the 
phenobarbitone induction of microsomal cytochrome P-450 and 
hydroxylating enzymes (4, 48). 
4. EFFECT OF DIETARY CARBOHYDRATE DEFICIENCY 
Investigations on the effects of different dietary protein 
levels on drug metabolism, were done essentially by replacing the 
protein content of the diet by carbohydrates. Thus, the high-protein 
diets were essentially carbohydrate-deficient diets. This led 
Nakajima et al. (49) to believe that the effects of protein in drug 
metabolism were actually that of carbohydrates. In their study, the 
effects of protein, fat and carbohydrate were examined by utilizing a 
series of diets in which the content of one of the nutrients is 
varied at the expense of one of the other two nutrients without 
changing the total caloric content. They demonstrated that feeding a 
sucrose-free diet for one day resulted in increased metabolic rates 
of hydrocarbons comparable to that found in rats that had been 
completely deprived of food for one day. Diets with decreased 
sucrose content resulted in increased metabolism of hydrocarbons, 
whereas diets with varied protein or fat content (the sucrose content 
being constant) did not result in significant changes in the 
metabolism of hydrocarbons examined. Therefore, they concluded that 
the reported effects of protein, fat and one-day fasting were 
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actually the effects of carbohydrate (49). The effects of high and 
low dietary carbohydrate on hepatic drug metabolism was investigated 
by Sonawane et al. (3) utilizing starch and sucrose. They 
demonstrated that a low-starch or low-sucrose diet for four weeks 
resulted in an increased hepatic microsomal protein concentration 
while the cytochrome P-450 content and aminopyrine demethylase 
activity were decreased. The cytochrome P-450 content in the control 
animals when compared to that in the low-starch and low-sucrose 
animals were 0. 62 + 0. 02 vs 0. 48 � 0. 025 and 0. 50 � 0. 021 nmoles/mg 
protein, respectively. The aminopyrine demethylase activity in the 
control animals was 39. 6 + 0. 04 whereas the activities in the 
low-starch and low-sucrose animals were 21. 0 + 0. 60 and 19. 0 + 0. 74 
nmoles/mg protein/20 min incubation, respectively. The 
p-nitrophenol-UDP-glucuronyltransferase activity on the other hand 
was significantly increased from the basal rate (20. 2 � 0. 60 , 32. 2 + 
1. 66 and 32.9 � 1. 63 nmoles/mg protein/5 min incubation, for the 
control, low-starch and low-sucrose groups respectively) (3). 
5. EFFECT OF VITAMIN DEFIC IENCY 
Fat-soluble vitamins 
Rats fed a vitamin A-deficient diet were reported to have 
significantly lower hepatic drug hydroxylation and demethylation 
activities and cytochrome P-450 content (50). Siddik et al. (51) 
reported that weanling rats fed a vitamin A deficient diet for eight 
weeks had lower hepatic cytochrome P-450 contents and 
N-methyl-p-chloroaniline N-demethylase activity, however, the 
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activities of NADPH-cytochrome C reductase, p-nitrobenzoic acid 
nitroreductase and biphenyl hydroxylase were not affected. Their 
findings are supported by the recent observations of Dogra et al. 
(52) who reported that vitamin A deficiency for five to six weeks 
resulted in decreased cytochrome P-450 content (0. 74 + 0.10 vs 0. 09 
nmoles/mg protein), benzo (a)pyrene hydroxylase (146. 00 + 18. 93 vs 
90. 00 ± 22. 76 picomoles/mg protein/min) and UDP-glucuronyltransferase 
(2. 67 ± 0. 47 vs 2. 40 _: 0. 27 nmoles of product formed/min/mg protein) 
activities (52). The molecular role of vitamin A in drug metabolism 
has not yet been elucidated (51) and it has been suggested that 
vitamin A may have a structural role in membranes (53), thus 
affecting drug metabolism. Vitamin E deficiency has been also 
reported to result in decreased drug metabolism (54). Not much 
information was available on the effects of diets deficient in the 
other fat soluble vitamins (D and K) on drug metabolism. 
Water Soluble Vitamins 
Wade et al. (55), in feeding rats 0, 0. 03, 0.11, 0. 20, 0. 49, 
1. 0, 2.9, 7.0, 15.0, 30, 50, 100, 500 and 2000 g thiamine HCl daily, 
reported that the in vitro metabolism of heptachlor and aniline 
decreased as the level of thiamine intake increased. In vitro 
hexobarbital metabolism, on the other hand, was unaffected by the 
different levels of thiamine intake. Their findings were consistent 
with observations by Grosse and Wade (56), who reported a 
significantly lower drug metabolism in rats receiving a high-thiamine 
diet. They suggested that the higher drug metabolism rates found in 
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rats fed the lower thiamine diet may be due in part to the effects of 
chronic feed restriction since the animals on the low-thiamine diets 
consumed less feed and gained significantly less weight than those 
fed by the high-thiamine diet (55). 
Since the hepatic microsomal electron transport chain 
involves the NADPH-specific flavoprotein (NADPH-cytochrome c 
reductase), Catz et al. (57) investigated the effects of riboflavin 
deficiency in mice and reported an initial decrease in hexobarbital 
sleeping time after ten days on the deficient diet, but a threefold 
increase in the sleeping time one week later when compared to the 
controls. However, they could not correlate their in vivo 
observations with the in vitro rates of metabolism of the type I 
substrates, namely aminopyrine and hexobarbital, which remained 
unaffected. The cytochrome P-450 content and aniline hydroxylase 
activity were increased while benzopyrene oxidation was decreased 
(57). 
Numerous studies in vivo and in vitro have demonstrated that 
the metabolism of drugs by the mixed-function oxidase system is 
decreased in ascorbic acid deficiency. These studies have revealed 
that an ascorbic acid deficiency resulted in decreased cytochrome 
P-450 content, cytochrome b5 level, cytochrome P-450 reductase, 
aniline hydroxylase and benzphetamine N-demethylase activities 
(58-64) however, cytochrome C reductase activity, was unaffected 
(63). The biochemical basis for the role of ascorbic acid in drug 
metabolism has yet to be elucidated, although recent studies by 
Turnbull and Omaye (62) suggested a role in the assembly of the 
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active form of cytochrome P-450, including apocytochrome synthesis 
and the incorporation of Fe2
+ 
in the heme moity of cytochrome P-450. 
6. EFFECT OF STARVATION 
Starvation has long been known to influence drug metabolism, 
and Gram et al. (65) pointed out that different microsomal enzymes 
responded differently to the effects of starvation. Starvation for 
one to three days has been shown to have no effect on hepatic 
microsomal protein concentration (10, 66-68), cytochrome P-450 content 
(8, 66-69) and cytochrome c reductase activity (69), although Pessayre 
et a 1 • ( 69) reported an in crease in the micros oma 1 protein 
concentration after a 42-hour fast. Impaired metabolism of 
aminopyrine and hexobarbital was observed in starved male rats by 
Kato and Gillette (10). Certain drug metabolizing enzymes such as 
ethylmorphine demethylase (68, 69) and benzopyrene hydroxylase (69) 
were also reported to be decreased, while aniline hydroxylase (237 + 
16 vs 388.: 25 nmoles/g liver/30 min incubation) (10), 
nitroso-dimethylamine demethylase (70) and p-nitroanisole demethylase 
(69) were increased following a period of fasting. Glucuronyl 
transferase activity has been reported to increase with fasting (66, 
71 ). Duval des tin et al. (71) in their study of UDP-gl ucuronyl 
transferase using bilirubin, phenolpthalein and p-nitrophenol as 
substrates found that only the bilirubin UDP-glucuronyltransferase 
activity was increased after a 3-day fast. Previously, Bock et al. 
( 72) and Zak im et al. ( 73) had stated that the gl ucuronyltransferases 
were a heterogeneous group of closely related enzymes with different 
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specific substrates and the results of Duvaldestin et al. (71) lend 
further support to this argument, while demonstrating the variability 
of the response of certain enzymes to fasting. 
When interpreting the in vitro activities of these enzymes to 
fasting, one often has to take into account the change in liver size. 
Fasting has been demonstrated to result in a decreased liver weight 
(65) as well as a decreased liver weight/body weight ratio (69). This 
decrease in liver size translated into lesser amount of total enzyme 
activity as demonstrated by Marselos and Laitinen (8) and Duvaldestin 
et al. (71), although increased in vitro activities of various 
hepatic microsomal drug metabolizing enzymes calculated per whole 
liver have been reported in rats fasted for three days (67). 
The overall effect of fasting in general is a decrease in drug 
metabolism (10,74, 75). 
In severe starvation (up to four days), Carlson (76) reported 
an induction of the drug metabolizing enzyme system and suggested 
that the severe starvation probably mobilized the xenobiotics in the 
fat stores and thus induced the drug metabolizing system. Presumably, 
polychlorinated biphenyls are stored in body fat for considerable 
periods of time (77). 
7. EFFECT OF FEED RESTRICTION 
Studies examining the effects of prolonged partial food 
restriction on the metabolism of drugs and environmental xenobiotics 
are rather limited. Sachan (14) reported that feed restriction at 45% 
for 28 days resulted in a significant decrease in hexobarbital 
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sleeping time, and increased hepatic cytochrome P-450 content and 
activities of drug metabolizing enzymes. NADPH-generating enzymes 
were also reported to be increased by the 45% feed restriction. These 
findings were supported by the observations of Sachan and Das (16) 
where increases in drug metabolizing enzymes as well as the 
NADPH-generating enzymes were reported when rats were feed restricted 
at 50% for a period of 49 days. These studies indicate that prolonged 
feed restriction results in increased drug metabolism unlike that 
observed in starvation or single nutrient deficiencies. Since only 
one level of feed restriction was examined in each of these studies, 
it was not possible to determine at what degree of feed restriction 
these change would occur. We examined this question in a recent study 
where 15, 30 and 45% feed restriction were imposed for four weeks and 
found that 45% feed restriction was most effective in altering 
certain drug metabolizing enzymes but not others (15). 
None of these studies provided information about the duration 
of restriction necessary at any level of feed restriction at which 
changes in DME would be expected to be seen first. It was argued that 
perhaps this concern may be best resolved by simultaneously examining 
the effects of degree and duration of feed restriction. Therefore, in 
the current study, the effect of both the level as well as the 
duration of feed restriction on drug metabolism was undertaken to 
examine these issues. 
CHAPTER III 
PROCEDURE 
1 • EXPERIMENT I 
Experimental Design 
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Male weanling Sprague-Dawley rats (Harlan Sprague-Dawley 
Inc., Indianapolis, Indiana) weighing approximately 60 g were divided 
into a control group of 20 animals and 15 treatment groups of five 
animals each. The animals were allowed to aclimatize to the 
laboratory conditions for one week before the onset of the 
experiment. The beginning dates of the experiment for each block of 
animals were staggered so that only a maximum of ten animals will 
have completed the duration of experiment on each termination day. 
All animals were of the same age when they started on the experiment 
and they were all terminated at the end of the five week experimental 
period. The animals were individually housed in 7 11 x 10 11 x 7 11 wire 
mesh stainless steel cages and distilled water was made available ad 
libitum. The animals in group 1 (control group) were fed a 
semi-synthetic normal diet (Table 1) ad libitum. Groups 2 through 6, 
7 through 11, and 12 through 16 were given the same semi-synthetic 
diet at a level equal to 85%, 70% and 55%, respectively, of the 
average amount consumed by the ad libitum group on the preceding day. 
The duration of restriction for each level of restriction was from 
one to five weeks depending on the treatment group (Table 2). All 
animals were sacrificed at the end of a five-week experimental 
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COMPOSITION OF THE EXPERIMENTAL DIET 
Ingredient 
Composition 
(%) 
Casein 
Sucrose 
Cornstarch 
Alphacel 
Crisco 
Wesson Oil 
Vitamin mix 1 
Salt mix2 (with se3 & zn4) 
20.0 
29. 0 
31. 0 
6.0 
6.0 
2.0 
2.0 
4.0 
1vitamin diet fortification mixture, ICN Pharmaceuticals 
Inc., Life Sciences Group, 26201 Miles Road, Cleveland, Ohio 44128. 
Composition per kg of mixture: (in g) vitamin A concentrate 
(200, 000 IU/g), 4.5 ; vitamin D concentrate (400, 000 IU/g) 0.25 ;  
-tocopherol, 5.0 ; ascorbic acid, 45.0 ; inositol, 5.0 ; choline 
chloride, 75.0 ; menadione, 2.25 ;  p-amino benzoic acid, 5.0 ; niacin, 
4.5 ; riboflavin, 1 .0 ;  pyridoxine hydrochloride, 1.0 ; thiamin 
hydrochloride, 1.0 ; calcium pantothenate, 3.0 ; (in mg) biotin, 20 ;  
folic acid, 90 ; vitamin B-12, 1.35. 
2Hubbell, Mendel and Wakeman salt mixture, I CN 
Pharmaceuticals Inc., Life Sciences Group, 26201 Miles Road, 
Cleveland, Ohio 44128. Composition of mixture: calcium carbonate 
54.3% ;  magnesium carbonate 2.5% ; magnesium sulfate (7H20) 1.6% ; 
sodium chloride 6.9%, potassium chloride 11.2% ; potassium phosphate 
(monobasic) 21.2% ;  ferric phosphate 2.05% ; potassium iodide 0.008% ; 
manganese sulfate (H20) 0.035% ; sodium fluoride 0.10% ; aluminum 
potassium sulfate 0.017% ; copper sulfate (5H
2
0) 0.09%. 
3NaSeo
4
@ 0.0003% of salt mix. 
4 ZnC0
3
@ 0.06% of salt mix. 
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TA BLE 2 
EX PER IMENTAL DES I GN FOR EX PER IMENT I 
Leve l  of Durat i on of Ons et of Feed Res tr i c t i on 1 Dur i n g  the  
Gro up  N o .  of F eed  F eed Ex per i men t a l  Per i od (wee k ) 
N o .  An i m a l s Restr i c i t on Restr i ct i on 1 2 3 4 5 
1 20 0% 0 
2 5 1 5%  1 week  -- - - - - - - >  
3 5 15 %  2 weeks  -- - - - - - - - - - - - - - >  
4 5 1 5%  3 weeks  - - - - - - - - - - - - - - - - - - - - - - >  
5 5 15%  4 week s  --- - - - - - - - - - - - - - - - - - - - - - - - - - - >  
6 5 15%  5 weeks  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - > 
7 5 30% 1 week - - - - - - - - >  
8 5 30% 2 week s  -- - - - - - - - - - - - - - >  
9 5 30% 3 weeks  - - - - - - - - - - - - - - - - - - - - - - >  
10 5 30% 4 weeks  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - >  
1 1  5 30% 5 weeks  --- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - > 
12 5 45%  1 week  -- - - - - - - >  
13  5 45% 2 weeks  - - - - - - - - - - - - - - - >  
14 5 45% 3 week s  - - - - - - - - - - -- - - - - - - - - - - >  
1 5  5 45 % 4 weeks  - - - - - - - - - - - - - -- - - - - - - - - - - - - - - > 
16 5 45% 5 week s  - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - - >  
1A l l  an i ma l s were fed a d  l i b i t um unt i l  t h e  on s et o f  the i r  res pec t i ve 
res tr i ct i on per i ods . 
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period. All animals were fed ad libitum until the onset of their 
respective restriction periods. For example, if the restriction was 
for a period of two weeks, the animals in that group would be fed ad 
libitum for the first three weeks and then feed restricted during the 
last two weeks of the experimental period. Thus the animals also 
served as their own controls during the first period of the 
experiment. Due to the large number of animals involved, and the fact 
that only a maximum of ten animals could be handled and processed 
properly at a given time, an incomplete block design was employed. 
The designation of the animals to the block are described as follows: 
Attempts were made to achieve approximate balance in the 
incomplete block design utilizing procedures available in general 
linear models (GLM) of Statistical Analysis Systems (SAS) 1979 (78). 
Animals were randomly assigned (on paper) to €ach block manually and 
then a computer analysis of the design was run using a 
pseudo-response variable for the purpose of looking at relative 
standard errors among the least square means of the treatment group. 
While inspecting the standard error and looking at the 
effective number of animals per treatment, if the standard errors 
were found to be greatly different from each other, the animals were 
reassigned within the block and the design reanalyzed. The process 
was repeated until all the standard errors were within a close range 
of each other. This was to ensure that 1) all treatment groups were 
estimable and 2) each treatment mean was estimated with approximately 
the same precision. 
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Sample Collection and Analysis 
At the end of the five-week experimental period, the animals 
in Experiment I were sacrificed under sodium Brevital (Eli Lilly and 
Co. , Indianapolis, Indiana) anesthesia. Blood was collected in 
heparinized tubes (approximately 0. 2 ml of 5 mg/ml heparin solution 
per 7 ml of whole blood) by heart puncture and plasma was obtained by 
centrifugation at 1500 x g at 4°C for ten minutes in a refrigerated 
centrifuge (Model J -6 8, Beckman Instruments, Palo Alto, CA) and 
stored in a freezer at -60°C. The viscera was exposed and a portion 
of the right lateral lobe of the liver was freeze-clamped with a pair 
of flat thongs with aluminum jaws (made by riveting 6 x 2 x 1 cm3 
aluminum blocks to the jaws) previously chilled in liquid nitrogen. 
The frozen piece of liver was weighed quickly and then stored in a 
freezer at -6o 0c until analyzed. Various organs such as heart, 
kidney, skeletal muscle and small intestine were excised quickly, 
frozen immediately in liquid nitrogen and stored in a freezer at 
-60°C for possible future analyses. The rest of the liver was 
excised, weighed, minced with a pair of surgical scissors while on 
ice. A small portion of the minced liver was stored at -60°C for 
future analyses and the remaining portion used for subcellular 
fractionation, immediately. 
Subcellular Fractionation 
The freshly minced liver was homogenized (3 strokes) in three 
volumes of buffer (1. 15% KCl--0. 01 M KP04 phosphate, pH 7. 4) in a 
glass homogenizer with a teflon pestle driven by a low -speed motor 
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whi le on ice. The homogenizer was then rinsed with the buffer and 
more buffer was added to the homogenate to obtain a concentration of 
approximately 12% ( w/v). The homogenate was centrifuged at 10, 000 x 
g for 10 minutes at 4°C. A portion of the supernatant (SN) was saved 
and frozen at -60 °C for further ana lyses whi le the remainder of the 
10, 000 x g SN was centrifuged at 100, 000 x g for 1 hr. at 4°C (Mode l  
L5-50 Ultracentrifuge, Beckman Instruments, Inc., Palo A lto, CA). An 
aliquot of the 100,000 x g SN was then saved and frozen at -60°C 
until ana lyzed whi le the pel let ( microsomes) was resuspended in a 
glycerol: phosphate buffer ( 1 : 1-glycerol -0. 15 M KP04, pH 7. 8) without 
washing. The vo lume of the homogenate, various supernatants, and the 
microsoma l suspension were recorded at each stage to a l low for 
ca lcu lations of dilution factors. 
The microsomes were used to determine protein content ( 79) 
cytochrome P-450 content ( 21), and NADPH-cytochrome c reductase 
activity ( 80) immediately after preparation (usua l ly late afternoon). 
The remainder of the microsoma l suspension was frozen at -60°C until 
a liquots were used to determine the in vitro activities of aniline 
hydroxylase (81), p-ch loro-N-methylaniline demethylase (82) and 
UDP-glucuronyl transferase ( 83) on subsequent days (usua l ly within a 
week) with the exception of UDP-glucuronyl transferase. The 100,000 
x g SN were used to determine protein content ( 84), glucose 
6-phosphate dehydrogenase ( 85), 6-phosphogluconate dehydrogenase ( 85) 
and ma lic enzyme ( 86) activities. 
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Assay Procedure 
Before analyzing experimental samples, each assay procedure 
was subjected to quality control, i. e. substrate and time courses 
were established for the linear range of an assay. Microsomal protein 
content, Cytochrome P-450 content and NADPH-cytochrome c reductase 
activity were determined within 24 hours of termination while the 
100, 000x g SN protein and NADPH-generating enzymes were determined 
within 48 hours of termination. Aniline hydroxylase and 
PCMA-N-demethylase activities were determined within a week of 
termination while p-nitrophenol-UDP-glucuronyl transferase activity 
was determined within a year. 
Protein Determination 
Microsmal protein was determined by the procedure of Lowry et 
a 1 • ( 79 ) 
Reagents 
1. Sodium carbonate (Na2co3) in 0. 1 N sodium hydroxide (NaOH) 
2% (w/v): 6 g of Na2co3 was dissolved in 0. 1 N NaOH and brought up to 
a total volume of 300 ml. 
2. (0. 1 N) NaOH: 2 g NaOH was dissolved in glass distilled 
water (GOW) and brought up to a total volume of 500 ml. 
3. Cupric sulfate (Cuso4. 5H20), 1% (w/v): 0. 5 g CuS04. 5H20 
was dissolved in GOW and the total volume brought up to 50 ml. 
4. Sodium potassium tartrate (NaKC4H4o6. 4H20), 2% (w/v): l g 
of NaKC4H4o6. 4H20 was dissolved in GOW and brought up to a total 
vol ume of 50 ml . 
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5. Diluted folin reagent: Falin & Ciocalteu • s  phenol reagent 
(Fisher Scientific Co. , Fair Lawn, NJ) was diluted 1: 1 (v/v) with GOW 
and stored in an amber bottle at 4°C. 
6. Alkaline copper reagent: 0. 5 ml of the 2% NaKC4H4o6. 4H2o 
and 0. 5 ml of the 1% CuS04 . s H 20 solutions were added to 50 ml of the 
2% Na2 co3 in 0.1 N NaOH solution. The solution was mixed thoroughly 
to avoid precipitation of Cu (OH)2 • This solution was prepared just 
prior to the first run and discarded at the end of the day. 
7. Bovine serum albumin stock standard: 10 g of crystalline 
bovine serum albumin (ICN Pharmaceuticals, Inc., Life Sciences Group, 
Cleveland, OH) was dissolved in 100 ml of 0.9% saline. A working 
standard was made by diluting the stock standard to obtain a 
concentration of exactly 0. 5 mg/ml and kept at o0c .  
Procedure. The microsomal suspension was diluted tenfold with 
GOW and 0. 01 ml aliquots of the diluted microsomal suspension were 
used for the assay. Two ml of the alkaline copper reagent was added 
to the 0.01 ml aliquots of diluted microsomal suspension and the 
total volume was brought up to 3 ml with GOW in a test tube. The 
mixture was vortexed and allowed to stand at room temperature for at 
least ten minutes before 0.2 ml of the diluted folin reagent was 
added and followed immediately by vigorous mixing. The mixture was 
allowed to stand at room temperature for 30 minutes and the 
absorbance at 750 nm was measured (Spectronic 21, Bausch & Lomb Inc., 
Rochester, NY) against a reagent blank. The reagent blank was 
prepared by adding GOW in the place of the diluted microsomal 
suspension. A standard curve was determined by using seven 
28 
concentrations (5, 15, 30, 50, 60 and 75 �g) of the working serum 
al bumin standard in pl ace of the samp l e. A standard curve is shown in 
Figure 2. The ca l cu l ations were as fo l lows: 
where: 
Protein (pg/m l ) = AU/AS x CS x OF 
AU = absorbance of unknown 
AS = absorbance of standard 
CS = concentration of standard 
OF = di l ution factor 
100, 000 x g SN Protein Determination. 
Protein content in the 100, 000 x g SN was determined by the 
biuret technique as described by Gorna l l  et al. (84). 
Reagents. 
1. Biuret reagent : 90 g NaKC4H4o6. 4H2o was dissol ved in about 
400 m l  of 0. 2 N NaOH sol ution. Ten g of CuS04. sH20 and 10 g potassium 
iodide (KI) were added to it and the tota l vo l ume was made up to 2 
l iters with 0. 2 N NaOH. 
2. Standard bovine serum a l bumin : 10 g of crystall ine bovine 
serum (ICN Pharmaceutica l s, Inc., Life Sciences Group, Clevel and, OH) 
was dissol ved in 100 ml of 0. 9% sa l ine. A working standard was made 
by di l uting the stock solution to obtain a concentration of 40 mg/ml. 
Procedure. A 0. 4 ml a liquot of the 100, 000 x g SN was added 
to a test tube, and the vo l ume was made up to 1 ml with GOW. Five ml 
of biuret reagent was added and the sol ution was vortexed. After 
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Figure 2 .  Standa rd curve for microsomal protein obtaine d  with 
BSA at 750 nm . 
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standing for 30 minutes in room temperature, the absorbance was 
measured at 540 nm against a reagent blank. The reagent blank was 
prepared by adding GOW in place of the 100,000 x g SN. A standard 
curve was determined by using five concentrations (0. 04, 2. 0, 4. 0, 
8. 0 and 16. 0 mg) of the working serum albumin standard in place of 
the sample. A standard curve is shown in Figure 3. The calculations 
were as follows: 
where: 
Protein (mg/ml) = AU/AS x CS x OF 
AU = absorbance of unknown 
AS = absorbance of standard 
CS = concentration of standard 
OF = di l ution factor 
Cytochrome P-450 Content 
The cytochrome P-450 content in the microsomes was determined 
by the procedure of Om ura and Sato (21). The principle in this 
procedure is based on the carbon monoxide binding of the sodi um 
dithionite reduced cytochrome P-450 hemoprotein which has an intense 
absorbance peak at 450 nm. 
Reagents. 
1. 0. 6 M dipotassi um phosphate: 52. 25 g of K2HP04 was 
dissolved in GOW and brought up to a total vol ume of 500 ml. 
2. 0. 6 M monopotassi um phosphate: 20. 41 g of KH2Po4 was 
dissolved in GOW and brought up to a total volume of 250 ml. 
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3. 0. 3 M potassi um phosphate (KP0
4
) buffer: suff i c i ent 
volume of 0. 6 M KH2Po4 was added to 500 ml of 0. 6 M K2HP04 wi th 
cont i nuous sti rr i ng at room temperature unt i l  the pH meter regi stered 
7. 8. The resultant volume was doubled w ith GOW and the solut i on was 
kept refr i gerated. 
4. Glycerol-phosphate buffer: glycerol (Certi f i ed A. C. S. 
grade, F isher Sci ent i f i c  Co., Fai rlawn, NJ) was mi xed w ith an equal 
volume of 3 M  KP0
4
, pH 7. 8 solut ion and kept refr i gerated. 
5. Sod i um di thi oni te (Na2s2o4). 
Procedure. The mi crosomal suspensi on was d i luted wi th 
glycerol-phosphate buffer to obtai n  a suspensi on wi th a concentrat ion 
of 2 mg protei n/ml. To each of two 4 ml quartz cuvettes, 2. 5 ml of 
the d i luted mi crosomal suspensi on and 15 mg of Na2s 2o4 was added. The 
suspensi on was mi xed gently by i nverti ng the cuvettes and after 2 
mi nutes, the basel i ne at 450 nm was adjusted in  a double beam 
spectrophotometer (Model 34, Beckman Instruments, Inc., Palo Alto, 
CA). Carbon monoxi de was then bubbled through one of the cuvettes 
(sample cuvette) at approxi mately 40 bubbles per mi nute vi a a pasteur 
p i pette ti p for 60 seconds and the d i fference in  absorbance at 450 nm 
and 490 nm aga i nst the reference cuvette at room temperature was 
recorded. The exti nct ion coeff i ci ent of 91 mM-1cm-1 was used to 
calculate the concentrat i ons: 
where: 
Cytochrome P-450 (nmoles/mg prote i n) = A x  V x 1, 000 E X  MP 
A = d i fference in  absorbance between 450 nm and 490 nm 
V = volume of microsomal suspension in cuvette 
E = extinction coefficient (91 mM-1cm-1) 
MP = mg of microsomal protein present in the cuvette 
NADPH-Cytochrome C Reductase Activity 
The in vitro NADPH-cytochrome c reductase activity in the 
microsomes was determined according to the method of Williams and 
Kamin (80). The principle in this method involves the reduction of 
cytochrome c (which has an absorbance spectrum at 550 nm) by the 
enzyme in the presence of NADPH. 
Reagents. 
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1. Glycerol-phosphate buffer : as described previously under 
cytochrome P-450 content determination. 
2. Cytochrome c solution (4. 4 g/ml ) :  44 mg of cytochrome c 
(Sigma Chemical Co. , St. Louis, MO) was dissolved in 10 ml of 
glycerol-KP04 buffer, pH 7. 8. The solution was kept at o
0c .  
3. 0. 2 M sodium carbonate : 1. 06 g of anhydrous Na2co 3 was 
dissolved in 50 ml of GOW. 
4. 0. 2 M sodium bicarbonate : 0. 840 g of NAHC0
3 
was dissolved 
in 50 ml of GOW. 
5. 0. 1 M carbonate buffer, pH 10. 4 :  38. 5 ml of the 0. 2 M 
Na2co3 was mixed with 11. 5 ml of 0. 2 M NaHC03 and the total volume 
was brought up to 100 ml with GOW. 
6. Nicotinamide adenine dinucleotide phosphate (NAOPH) 
solution (8.6 mg/0. 5 ml) : 8.6 mg of NADPH was dissolved in 0. 5 ml of 
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the 0.1  M carbonate buffer, pH 10.4 and the solution was kept on ice. 
This solution was prepared fresh daily. 
Procedure. The diluted microsomal suspension (2 mg protein 
per ml) as described under the cytochrome P-450 assay, was used in 
this assay. To each of two 4 ml quartz cuvettes was added 1.6 ml of 
the 0.3 M KP04 buffer pH 7.8, 0.4 ml of the cytochrome c solution and 
0.02 ml of the diluted microsomal suspension. The cuvettes containing 
the mixtures were gently mixed by inverting, and then zeroed on a 
double beam spectrophotometer. The reaction was started by the 
addition of 0. 02 ml of the NA DPH solution to the sample cuvette at 
room temperature. The sharp increase in absorbance at exactly 550 nm 
was recorded over time on the plotter and the change in absorbance 
per minute was determined by the slope of the line. The extinction 
coefficient of reduced cytochrome c of 21 mM-1cm-1 was used in the 
calculations: 
where: 
Cytochrome c reductase activity (nmole cytochrome c 
reduced/min/mg protein) =!::,,.A x � x 1,000 
X MP 
� A  = change in absorbance per minute at 550 nm 
V = volume of mixture in the cuvette 
E = extinction coefficient ( 2 1  mM -l cm -l ) 
MP = mg of microsomal protein present in the cuvette 
Microsomal Aniline Hydroxylase Activity 
The in vitro microsomal aniline hydroxylase activity was 
determined according to the procedure of Imai and Sato (81). 
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The principle in this procedure involves the enzymatic 
hydroxylation of aniline by the mixed function oxidase system in the 
microsomes to yield 4-0H-aniline (p-aminophenol). The protein 
fraction of the incubation mixture was then precipitated by 
trichloroacetic acid (TCA). The PAP was converted to indophenol and 
measured spectrophotometrically. 
an i 1 in e MFO :> p-aminophenol --------;)>indophenol 
Reagents. 
1. 0.2 M KP04., pH 7.4 : prepared as described under 6PGD 
assay. 
2. 0.2 M G6P : 0.28 2 1  g of G6P-Na was dissolved in 5.0 ml of 
GOW. 
3. 0.1 M NADP : prepared as described under 6PGD assay. 
4. 0.5 M nicotinamide : 1. 221 g of nicotinamide (niacinamide) 
(Sigma Chemical Co. , St. Louis, MO) was dissolved in GOW and brought 
to a total volume of 20 ml. 
5. 0.5 M MgC12 : 5.0825 g of MgC12.6H20 was dissolved in GOW 
and brought up to a volume of 50 ml. 
6. Stock G6PD (220 units/ml) : 1 mg of solid G6PD (220 units) 
(Sigma Chemical Co., St. Louis, MO) was dissolved in 1 ml of 0.01 M 
KP04, pH 7.4. 
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7. G6PO (22 units/ml) : 0. 25 ml of the stock G6PO was diluted 
to 2. 5 ml with 0. 01 M KP04, pH 7. 4. 
8. 0. 01 M KP04 buffer, pH 7. 4: 5 ml of the 0. 2 M KP04, pH 7. 4 
was diluted to 100 ml with GOW. 
9. 0. 1 M aniline: 0. 92 ml of aniline hydrochloride (Sigma 
Chemical Co. , St. Louis, MO) was diluted to 100 ml with GOW. 
10. 10% (w/v) trichloroacetic acid (Cl
3
cco2H): 100 g of 
c 1
3
cco2H (TCA) (Fisher Scientific Co. , Fair Lawn, NJ) was dissolved 
in GOW and the total volume brought up to one liter. 
11. 10% Na2co3: 10 g of Na2co3 was dissolved in GOW and the 
total volume brought up to 100 ml. 
12. 0. 2 N NaOH-2% phenol: 2 g of phenol was dissolved in 10 
ml of 2 N NaOH and the total volume brought up to 100 ml with GOW. 
13. NADPH generating system: a NADPH-generating system was 
prepared to deliver in each 0. 63 ml aliquot, 0. 15 ml of G6P (#2), 0. 3 
ml of NADP (#3), 0. 05 ml of nicotinamide (#4), 0. 03 ml of MgC12 (#5) 
and 0. 1 ml of G6PD (#7). 
14. 0. 1 M p-aminophenol (PAP): 0. 1093 g of p-aminophenol 
(NH2C6H40H) (Fisher Scientific Co . ,  Fair Lawn, NJ) was dissolved in 
100 ml of 95% ethanol. 
Procedure. The reaction mixture in a 25 ml Erlynmeyer flask 
contained 1. 5 ml of the 0. 2 M KP04 buffer, 0. 63 ml of the NADPH 
generating system, 0. 3 ml of the microsomal suspension (approximately 
3 mg protein) and 0. 42 ml of GOW. This was preincubated at 37 °C in a 
shaking water bath (100 shakes per minute). The reaction was 
initiated by the addition of 0. 15 ml of 0. 1 M aniline. At the end of 
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the 15-minute incubation period, 1 ml of the 10% TCA was added to 
terminate the reaction. 
The resultant mixture was chilled on ice and then centrifuged 
at 2, 000 x g for ten minutes at 4°C. 1 ml of the TCA supernatant was 
added to 0. 5 ml of 10% Na2co 3 followed by 1 ml of 0. 2 N NaOH 
containing 2% phenol. This mixture was allowed to stand for 30 
minutes at room temperature before the absorbance at 630 nm was 
determined. A standard curve was determined using five concentrations 
(1, 5, 10, 20 and 30 µl) of 0. 01 M PAP and bovine serum albumin (3 mg 
protein per volume) in place of the microsomal suspension. A 
standard curve is shown in Figure 4. The calculations for the enzyme 
activity are as follows : 
where: 
Aniline hydroxylase activity (nmoles of PAP formed/min/mg 
protein) = AU/AS x CS x DF/T 
AU = absorbance of unknown 
AS = absorbance of standard 
CS = concentration of standard 
OF = dilution factor 
T = incubation time in minutes 
Microsomal p-Chloro-N-Methylaniline (PCMA) Demethylase Activity 
The PCMA-N-demethylase activity in the microsomes was 
determined according to the procedure of Kupfer and Bruggeman (82). 
The principle of this assay involves the enzymatic N-demethylation of 
PCMA by the mixed function oxidase system in the microsomes to yield 
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p-chloroaniline (P CA). The product is then reacted with a color 
reagent, p-dimethylamine-benzaldehyde, to form a color complex that 
absorbs light at 450 nm. 
PCMA MFO > PCA 
Reagents. 
��c_ol_o_r_
R
��-e_ag�e_n_t�-> color complex 
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1. 0. 1 M tris-HCl buffer, pH 7. 4 :  3. 0275 g of 
Tris (hydroxymethyl)aminomethane (Trizma Base) (Sigma Chemical Co. , 
St. Louis, MO) was dissolved in approximately 200 ml of GOW and the 
pH adjusted to 7. 4 with 6N HCl. Then the total volume was brought up 
to 250 ml with GOW. 
2. 0. 2 M G6P : prepared as described under aniline hydroxylase 
assay. 
3. 0. 15 M KCl :  0. 5592 g of KCl was dissolved in 50 ml of GOW. 
4. 0. 5 M MgC 12 : prepared as described under aniline 
hydroxylase assay. 
5. 0.01 M NADP : prepared as described under 6PGD assay. 
6. G6P O  (22 units/ml) : prepared as described under aniline 
hydroxylase assay. 
7. 0. 125 M PCMA : 0. 038 ml of p-chloro-N-methylamine (Sigma 
Chemical Co., St. Louis, MO) was added to approximately 5 ml of GOW 
containing 0. 05 ml of 6 N HCl and the total volume brought up to 10 
ml. This solution was stored in the dark in the refrigerator since it 
is light-sensitive. 
8. Color reagent : 6 g of p-dimethylaminobenzaldehyde (Eastman 
Kodak Chemical Co. , Rochester, NY) was added to approximately 50 ml 
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of GOW and 8. 32 ml of concentrated sulfuric acid (H2so4). The total 
volume was then brought up to 100 ml with GOW. 
9. Incubation mixture: an incubation mixture was prepared to 
deliver in a 4. 51 ml aliquot, 2. 5 ml of 0. 1 M tris-HCl buffer, 0. 06 
ml of 0. 2 M G6P, 0. 4 ml of 0. 15 M KCl and 1. 55 ml of GOW. 
Procedure. In a 25 ml Erlynmeyer flask the following was 
added : 4. 51 ml of incubation mixture, 2 mg of microsomal protein, 
0. 05 ml of 0. 5 M MgC1 2, 0. 03 ml of 0. 01 M NAOP, 0. 03 ml of 22 
units/ml G6PO and GOW to bring the total volume to 5 ml while 
allowing room for 0. 03 ml of 0. 03 M PCMA. The mixture was 
preincubated at 37° c for 5 minutes in a shaking (100 shakes per 
minute) water bath. The reaction was initiated by adding the 
substrate (0. 03 ml of 0. 03 M PCMA). At the end of the 20-minute 
incubation period, the reaction was terminated by the addition of 2 
ml of the color reagent. The resultant mixture was centrifuged at 
12,000 x g for 10 minutes and the absorbance of the supernatant 
determined at 445 nm against a blank prepared by adding the substrate 
after the reaction was terminated. To prevent any possible color 
stratification due to the high centrifugation, the supernatant was 
pipetted off into another tube and mixed gently by inverting before 
the absorbance determination. The extinction coefficient of 15. 209 
mM-1cm-1 was used in the calculation. 
PCMA-N-demethylase activity (nmoles/min/mg protein) 
= 
A x  OF x 1, 000 
E X  MP X T 
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where: 
A = absorbance of the sample 
E = extinction coefficient (15.209 mM-1cm-1) 
MP = mg of microsomal protein 
DF = dilution factor 
T = incubation time in minutes 
Resuspension of Microsomes 
In our investigations, we observed that the microsomes 
suspended in the glycerol-0.15 M KP04 buffer did not provide adequate 
UDP-glucuronyl transferase activities. However, when the same 
microsomes were resuspended in 0.154 M KCl, the U DP-glucuronyl 
transferase activity was directly proportional to the protein content 
of microsomes in the assay mixture (unpublished observations). 
Therefore, all the microsomes suspended in the glycerol-0.15 
M KP04 buffer were resuspended in 0. 1 54 M KCl as follows. An aliquot 
of 0.8 ml of the microsomes suspended in glycerol-0.15 M KP04 buffer 
was taken in an ultracentrifuge tube and 0.154 M KCl was added to 
bring the total volume to 10 ml. This suspension was gently mixed by 
inverting the tubes and then centrifuged at 100, 000 x g for 1 hr. at 
4°C. The supernatant was decanted and the top of the pellet was 
rinsed with 1 ml of 0.154 M KCl without disturbing the pellet. Then 
the microsomal pellet was resuspended in 1 ml of 0.154 M KCl. 
Protein Determination of 0.154 M KCl Suspended Microsomes 
The protein determination of 0.154 M KCl resuspended 
microsomes was done according to the procedure of Lowry et al. (79). 
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A l l steps done were simi l ar to the procedure described ear l ier for 
the microsoma l suspension except that the 0. 154 M KC l suspended 
microsomes were assayed instead of the g l ycerol -0. 15 M KP04 buffer 
suspended microsomes. During the resuspension of the microsomes , 
some protein content may be l ost. Thus the protein content of the 
new suspension (in 0. 154 M KC l)  was determined in order to faci litate 
ca l cu lations based on per mg protein or per gram liver. 
Microsoma l  p-Nitrophenol UDP-G l ucuronyl Transferase Activity 
The microsoma l UDP-gl ucuronyl transferase activity was 
determined according to the procedure of Graham and Wood (83). 
The principl e  of this procedure invol ves UDP-gl ucurony l 
transferase (UDP-GT) catal yzed transfer of a gl ucuronyl residue from 
uridinediphosphog l ucuronate (UDPGA) to an ag l ycone (p-nitropheno l)  to 
form the corresponding gl ucuronide and uridine phosphate (UDP). 
p-Nitropheno l is used as the phenol ic substrate and the enzyme 
activity is measured as the disappearance of p-nitrophenol which has 
an absorbance peak at 400 nm. 
UDPGA + ag l ycone UDP-GT )>gl ucuroni de + UDP 
Reagents. 
1 -2 1. 8. 33 x O M K2HP04: 1. 4512 g of K2HP04 was dissol ved in 
GOW and the tota l vo l ume brought up to 100 m l . 
1 -2 2. 8. 33 x O M KH
2Po4
: 1. 1341 g of KH2Po4 was dissol ved in 
GOW and the tota l vo l ume was brought up to 100 m l .  
3. 8. 33 x 10-2 M KP04 , pH 7. 1 :  the 8. 33 x 10
-2 M KH2P04 was 
added to 100 ml of 8. 33 x 10-2 M K2HP04 to get a pH of 7. 1. 
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4. Reaction mixture B: 1. 854 mg of p-nitrophenol was 
dissolved in 20 ml of 8. 33 x 10-2 M KP04, pH 7. 1. 
5. Reaction mixture A: 0. 0232 g of UOPGA ammonium salt (Sigma 
Chemical Co.,  St. Louis, MO) was dissolved in 6 ml of reaction 
mixture B. 
6. 2% TCA: 10 g of TCA was dissolved in 500 ml of GOW. 
7. 10 N KOH: 285 g of KOH was dissolved in GOW an d the total 
volume brought up to 500 ml. 
Procedure. A 0. 2 ml aliquot of the 0. 154 M KCl suspen ded 
microsomes was added to each of two test tubes containing 0. 3 ml of 
either reaction mixture A or reaction mixture B that had been 
preincubated at 37°C for three minutes. The reaction was allowed to 
proceed at 37°c with agitation for 30 minutes before being terminated 
by the addition of 4 ml of 2% TCA. This suspension was then 
centrifuged at 760 x g for ten minutes at 4° C. A 1 ml aliquot of the 
supernatant thus obtained was added to another tube containing 0. 06 
ml of 10 N KOH. The absorbance of the sample was read at 400 nm 
against a blank containing reaction mixture B an d 0. 2 ml of GOW. A 
stan dard curve using six volumes (15, 75, 113, 150, 225 an d 300 ; 1) 
of 6. 67 x 10-4 M p-nitrophenol instead of the sample in reaction 
mixture B is shown in Figure 5. The calculations for the 
p-nitrophenol UOP-glucuronyl transferase activity are as follows: 
UOP-glucuronyl transferase activity (nmoles of p-nitrophenol 
con jugated/min/mg protein = ABAS 
AA x CS x OF 
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where : 
AB = absorbance of the sample in reaction mixture B 
AA = absorbance of the sample in reaction mixture A 
AS = absorbance of the standard 
cs = concentration of the standard 
OF = dil ution factor 
6-Phosphogluconate Dehydrogenase Determination in the 100, 000 x g SN 
The determination of 6-phosphogluconate dehydrogenase (6PGD) 
activity is based on formation of NADPH (measured by the increase in 
absorbance at 340 nm) when 6-phospho-D-gluconate (6PG) is oxidized to 
ribulose-5-phosphate as follows: 
6-phospho-D-gl uconate + NADP
+ 6PG� ri bulose-5-phosphate + 
NADPH + H
+ 
+ CO2 
The procedure of Glock and McLean (85) was employed with some 
modifications. It was previously determined in our laboratory that 
in an unpurified system such as the 100 , 000 x g SN, the addition of 
NADP alone to the reaction mixture in the sample cuvette containing 
the glycylglycine buffer, MgC 12 and 100, 000 x g SN without the 6PG 
substrate resulted in the endogenous enzyme activity as measured by 
increasing absorbance at 340 nm. This would result in a higher 
reading and thus an erroneous indication of the enzyme content. Thus, 
in our procedure, NADP was added to both cuvettes (to account for the 
other endogenous substrates) and the reaction was initiated by the 
addition of 6PG instead of the NADP. 
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Reagents. 
1. 0. 25 M glycylglycine buffer, pH 7. 6 :  1. 053 g of 
glycylglycine hydrochloride (Sigma Chemical Co., St. Louis, MO) was 
dissolved in approximately 15 ml of GOW. The pH was then adjusted to 
7. 6 with 2 N NaOH. The total volume was brought up to 25 ml and the 
solution kept refrigerated. 
2. 0. 4 M K2HP04: 13. 93 g of K2HP04 was dissolved in GOW and 
the total volume brought up to 200 ml. 
3. 0. 4 M KH2Po4: 10. 89 g of KH2Po4 was dissolved in GOW and 
the total volume brought up to 200 ml. 
4. 0. 2 M KP04 buffer, pH 7. 4 :  0. 4 M KH2Po4 was added to 200 
ml of the 0. 4 M K2HP04 until a pH of 7. 4 was obtained. The resultant 
volume was then doubled with distilled water. 
5. 0. 01 M nicotinamide adenine dinucleotide phosphate (NADP) : 
37. 2 g of NADP (Sigma Chemical Co., St. Louis, MO) was dissolved in 5 
ml of 0. 2 M KP04 buffer pH 7. 4 and stored at o
0c .  
6. 2. 7 mM NADP : 2. 7 ml of the 0. 01 M NADP was diluted to 10 
ml with 0. 2 M KP04, pH 7. 4 and stored at o
0c .  
7. 0. 5 M magnesium chloride (MgC1 2) :  10. 1 6  g of MgC1 2. 6H2 o 
was dissolved in GOW and the total volume brought up to 100 ml. 
8. 0. 05 M 6-phosphogluconic acid trisodium salt: 85. 5 mg of 
6PG-Na3 (Sigma Chemical Co., St. Louis, MO) was dissolved in 5 ml of 
GOW and stored in the refrigerator. 
Procedure. To each of two 4 ml quartz cuvettes 0. 5 ml of the 
0. 25 M glycylglycine buffer, pH 7. 6, 0. 1 ml of the 2. 7 mM NADP, 0. 1 
ml of the 0. 5 M MgC 12 and 0. 05 ml of the 100,000 x g SN was added. In 
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the reference cuvette, 2. 25 ml  of GOW was added to bring the tota l 
vol ume to 3 ml and in the samp l e  cuvette, 2. 15 ml of GOW was added to 
al l ow room for the addition of the substrate. The mixtures were mixed 
gent l y  by inverting the cuvettes and then zeroed in a doub l e  beam 
spectrophotometer. The reaction was started by the addition of 0. 1 ml 
of 0. 05 M 6PG-Na3 and the change in absorbance over time at 340 nm at 
room temperature was recorded on the chart p l otter. The change in 
absorbance per minute at 340 nm was determined from the pl ot and the 
extinction coefficient of 6. 22 mM-1cm-1 was used in the ca l cu lations: 
where: 
6PGD activity (nmo l es NAOPH produced/min/mg protein) 
=�A x V x 1, 000 
E x  MP 
�A = change in absorbance per minute at 340 nm 
V = vo l ume of reaction mixture in the cuvette 
E = extinction coefficient (6. 22 mM-1cm-1) 
MP = mg of 100,000 x g SN protein in the cuvette 
G l ucose-6-Phosphate Dehydrogenase Determination in the 100, 000 x g SN 
The g l ucose-6-phosphate dehydrogenase (G6PD) activity was 
determined according to the procedure of G l ock and McLean (85). In 
this procedure, the combined activity of G6PD and 6PGD in the 
presence of saturated concentrations of gl ucose-6-phosphate (G6P) and 
6PG were determined together and then the activity of 6PGD determined 
previousl y  was subtracted from the combined activities. 
The reaction included the formation of NADPH from the 
oxidation of G6P as well as those from the oxidation of 6PG. The 
oxidation of G6P is as follows: 
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Glucose-6-phosphate + NADP
+ G6P!:>gluconolactone-6-phosphate + 
NADPH + H
+ 
Reagents. 
1. 0. 2 M G6P: 0. 2821 g of G6P-Na (Sigma Chemical Co., St. 
Louis, MO) was dissolved in 5 ml of GOW. 
2. 0. 05 M G6P: 2. 5 ml of the 0. 2 M G6P was diluted to 10 ml 
with GOW. 
3. Other reagents were the same as those used for the 6PGD 
assay. 
Procedure. The assay procedure was similar to that described 
for the assay of 6PGD activity except for the addition of 0. 1 ml of 
0. 5 M G6P and 0. 1 ml of 0. 5 M 6PG as substrates instead of just 6PG. 
The amount of GOW added was adjusted accordingly to obtain a total 
volume of 3 ml in the cuvettes. The change in absorbance per minute 
at 340 nm was determined and the combined activities of G6PD and 6PGD 
were calculated as follows: 
where: 
G6PD + 6PGD activity (nmoles NADPH produced/min/mg protein) 
_ .6.A X V  X 1, 000 -
E x  MP 
.6. A  = change in absorbance per minute at 340 nm 
V = volume of reaction mixture in the cuvette 
E = extinction coefficient (6. 22 mM- 1cm-1) 
MP = mg of 100,000 x g SN protein in the cuvette 
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The activity of G6PD was calculated by subtracting the value 
for the 6PGD activity determined previously from the combined G6PD + 
6PGD activities. 
Malic Enzymes Determination in the 100,000 x g SN 
The activity of malic enzymes (ME) was determined according 
to the procedure of Ochoa (86). 
The reaction involves the conversion of L-malate to pyruvate 
resulting in the formation of NADPH which is measured by the increase 
in absorbance at 340 nm : 
L-malate + NADP
+
�.:), pyruvate + CO2 + NADPH + H
+ 
Our proced ure again was modified slightly to account for the 
reaction occuring after the addition of NADP to the mixture. NA DP was 
added to both cuvettes and the reaction was initiated by the addition 
of L-malate. 
Reagents. 
1. 0. 03 M L-malate-Na : 0. 2012 g of L-malate-Na (Sigma 
Chemical Co., St. Louis, MO) was dissolved in approximately 30 ml GOW 
and the pH was adjusted to 7. 0 with 2 N NaOH. The total volume was 
brought up to 50 ml with GOW. 
2. 0. 01 M NADP in glycylglycine buffer, pH 7.6 :  37. 2 mg of 
NADP was dissolved in 5 ml of 0. 25 M glycylglycine buffer, pH 7. 6 and 
stored at o0c .  
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3. 2. 7 mM NADP : 2. 7 ml of the 0. 01 M NADP was di l uted to 10 
ml with the gl ycy l g l ycine buffer, pH 7. 6. 
4. 0. 25 M gl ycy l gl ycine bu ffer, pH 7. 6 :  prepared as described 
previousl y under 6PGD assay. 
5. 0. 05 M manganese ch l oride (MnC 12) :  0. 1979 g MnC 12 was 
dissol ved in 20 ml GOW. 
Proced ure. To each of the two 4 ml quartz cuvettes 0. 3 ml of 
the 0. 25 M gl ycyl gl ycine buffer, 0. 06 ml of the 0.05 M MnC 12, 0. 05 ml 
of NADP and 0. 05 ml  of the 100,000 x SN was added to each cuvette to 
bring the tota l vol ume to 3 ml except that in the samp l e  cuvette, 
room was al l owed for the addition of 0. 05 M L-ma l ate. The reaction 
was initiated by the addition of 0.05 ml of the 0. 05 M L-ma l ate and 
the change in absorbance at 340 nm per minute was determined. The 
ca l cu l ations for the ME activity were as fo l l ows : 
where : 
ME activity (nmo l es NADPH prod uced/min/mg protein) 
= �A X 3 X 1 ,000 
E X  MP 
� A  = change in absorbance at 340 nm per minute 
E = extinction coefficient (6. 22 mM- 1cm- 1) 
MP = mg 100,000 x g SN protein in cuvette 
2. EXPERIMENT II 
Thirty ma l e  wean l ing Sprague-Daw l ey rats (Taconic Farms, 
Germantown, NY) weighing approximatel y  60 g were divided into two 
groups of ten anima l s  each. Anima l s  were housed in facil ities as 
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described for Experiment 1 and fed the same semi-synthetic diet. The 
animals in the first group (ad lib group) were fed the semi-synthetic 
diet ad libitum and the animals in the second group (45% restricted 
group) were given the same diet at an amount equal to 55% of that 
consumed by the ad libitum group the previous day. Distilled water 
was made av a i l ab l e to a 1 1  an i ma 1 s ad 1 i bit um . 
Cannulation of Right Jugular Vein 
At the end of the four-week experimental period, the right 
external jugular vein of these animals were cannulated according to 
the procedure of Upton (87). 
Surgical Equipment 
1. Fine forceps. (Accurate Surgical & Scientific Instruments 
Corp. , Westbury, NY.)  
2. Fine scissors. (Accurate Surgical & Scientific Instruments 
Corp., Westbury, NY.) 
3. Sma 1 1  scissors. 
4. Suture needles. 
5. Suture silk - 4-0. 
6. Small needle holder. 
7. Small forceps. 
8. Trochar - 14 gauge. 
9. Heparinized saline - 10 units/ml normal saline. 
10 • Sil as t i c ( 60 2 -13 5 ) t u bi n g , i. d. 0. 51 rrm , o. d. 0. 9 4 mn , -
150mm length with one end beveled at 45 , (Dow Corning International 
Ltd., Midland, MI). 
52 
11. Hypodermic needles - 24 gauge. 
12. Disposable syringes - 1 cc. 
13. Hematocrit sealing putty. 
14. Hair clipper. 
15. Neosporin antibacterial ointment, (Burroughs Wellcome Co., 
Research Triangle Park, NC). 
16. Ether an aes thes i a chamber. 
17. Ethyl ether, (Fisher Scientific Co., Fair Lawn, NJ). 
18. Resuscitator. 
19. Alcohol swabs, (American Scientific Products, McGaw Park, 
I L ) .  
Surgical Procedure 
The rat was anaesthetized with ether and the hair was removed 
from about a 3 cm square area above the right jugular vein. The area 
was sterilized with an alcohol swab. During the rest of the surgical 
procedure, anaesthesia was maintained by app l ying a 20 ml beaker 
containing a small wad of surgical gauze saturated with ether over 
the rat ' s  nose and mouth (care was taken to avoid suffocating the 
animal. An artificial resuscitation apparatus was constructed from a 
one way rubber bulb, rubber tubing and a plastic funnel. This was 
" used for emergency resuscitation when needed). 
The surgical procedure was carried out under aseptic 
conditions and all equipment were sterilized prior to the surgery. A 
small skin incision (approximately 1 cm) was made above the right 
jugular vein in an anterior direction starting from a point above the 
col l ar bone. By blunt dissection, approximately 75 mm of the right 
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jugular vein was exposed. A folded piece of suture thread was passed 
under the exposed vein and the loop cut to make two single strands of 
suture thread. The anterior end of the exposed vein was then ligated 
and the tie left uncut. The top surface of the exposed vein was 
picked up with a pair of fine forceps and a small obligue cut was 
made with a pair of fine scissors. The 150 mm silastic tubing was 
rinsed with heparinized saline before being inserted (beveled end 
first) into the vein and passed towards the heart (approximately 
30-40 mm). The tubing was then secured by tying the posterior of the 
two strands of suture thread firmly around the vein just below the 
point of insertion and again with another suture thread around the 
vein just above of the collar bone. The exposed tubing was further 
secured to the depleted section of the vein by the ends of the 
anterior ligature. The tubing was then inserted via a trochar, under 
the skin at a point in line with but anterior to the exposed section 
of the vein and passed subcutaneously to exit at a point on the back 
of the neck between the scapulae. A syringe charged with heparinized 
saline was attached to the tubing. Possible occlusion of the cannula 
was monitored after each tie and after the subcantenous insertion of 
the tubing by moving the plunger. The surgical wound was then closed 
with four or five interrupted sutures and Neosporin antibacterial 
ointment was applied. After the injection of 0. 2 ml heparinized 
saline, the cannula was cut to a length of approximately 3 cm and 
stoppered with a plug fashioned from a 24 gauge needle (the ends of 
the needle were plugged with hematocrit tube sealing putty). The 
animal was then allowed to recover from the anaesthesia for 3-4 hr 
before being dosed with antipyrine. 
Blood Antipyrine Clearance Determination 
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The blood clearance of antipyrine was determined according to 
the procedure of Knights et al. ( 88 )  
Reagents 
1. Cyproheptadine internal standard, 0. 4 mg/ml : 4 mg of 
cyproheptadine (Sigma Chemical Co. , St. Louis, MO) was dissolved in 
10 ml of GOW. 
2. Methylene chloride : Fisher Certified ACS Grade (Fisher 
Chemical Co. , Fair Lawn, NJ). 
3. Antipyrine (20 mg/ml) : 0. 5 g of antipyrine (Sigma Chemical 
Co., St. Louis, MO) was dissolved in 25 ml of normal saline. 
4. Antipyrine standard (2 mg/ml) : 1 ml of the 20 mg/ml 
antipyrine was diluted to 10 ml with normal saline. 
Procedure 
Antipyrine (40mg/kg body weight) was injected into the rat 
via the cannula followed by a 0. 2 ml flush of heparinized saline. 
Blood samples (0. 2 ml) were collected at 15, 30, 60, 90, 120, 180 and 
240 minutes post dosage as follows : Approximately 0. 2 ml of blood was 
collected in a 1 cc syringe via the cannula and transferred 
immediately into an eppendorf tube. Exactly 0. 1 ml aliquot of the 
blood was then immediately transferred into a heparinized eppendorf 
tube containing 10 ; 1 of 0. 4 mg/ml cyproheptadine, 100 pl of GOW and 
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50 pl of methylene chloride. (Fluid replacement was provided with 
0. 2 ml of normal saline after each sampling). The mixture was 
vortexed for 1 minute and centrifuged in an eppendorf centrifuge for 
2 minutes. The organic phase (1 µl) was injected into a gas liquid 
chromatograph (HP 5840A, Hewlett-Packard Instrument Co. , Mounta i n  
View, CA) fitted with a 2 m x 2mm ID glass column packed with 3% 
OV-25 on Gas Chrom Q - 80/100 mesh (Supelco Inc., Bellefonte, PA). 
The output for the nitrogen-phosphorus detector was monitored on the 
5840A integrator. The temperatures for the injection port, column and 
detector were 250° , 250° , and 300°C respectively. The flow rates 
for the helium carrier gas, detector hydrogen and air were 20, 3 and 
50 ml/minute respectively. 
A standard curve was prepared by adding the antipyrine 
standard to yield concentrations of 0, 0. 5, 1, 2, 3 and 5 fg/100 fl 
of whole blood (Figure 6). The antipyrine concentration was 
determined by comparing the area ratio of antipyrine to 
cyproheptadine in the sample with that of the antipyrine to 
cyproheptadine in the standard. The calculations were as follows :  
where : 
Antipyrine (pg/100 µl of blood) = aAU x aCS x cAS aCU x aAS 
aAU = area ratio of antipyrine in sample. 
aCU = area ratio of cyproheptadine in sample. 
aAS = area ratio of antipyrine in standard. 
aCS = area ratio of cyproheptadine in standard. 
cAS = concentration of antipyrine standard. 
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Pharmacokinetic Analysis 
Kinetic parameters of antipyrine were calculated according to 
the proced ures described by Gibaldi (89). 
The blood antipyrine data was plotted on semilogarithmic 
paper with the concentration of antipyrine in the blood on the y -
axis (logarithmic scale) and the time of sampling on the x - axis 
(linear scale). The straight line obtained was extrapolated back to 
time zero to obtain C
0
, the theoretical antipyrine concentration in 
the blood at time zero. The vol ume of distribution ( V ) was then 
calculated as follows: 
V = i. v. dose/C
0 
The elimination half-life (T112
) of antipyrine (i. e. the time 
required for the concentration to be red uced by 50%) was determined 
directly from the graph. 
The elimination constant (k) was calculated as: 
k = 0. 693/T
l/2 
The clearance rate (Cl) (amount of blood that is cleared of 
the dr ug in unit time) was calculated as : 
Cl = k x V 
3. EXPERIMENT III 
The animals in Experiment 3 were the same animals that were 
used for the antipyrine experiment. At approximately 36 - 42 days 
after the antipyrine experiment, the rats were gavaged with an oral 
LD50 (5. 4 mg/kg body weight) dose of carbon tetrachloride (Fischer 
58 
Chemical Co. , Fair Lawn, NJ). (The carbon tetrachloride was mixed 
with mineral oil in a 1: 1 (v/v) solution). The LD50 dose of 5. 4 
mg/kg body weight was the lower range of the LD50 dose for rats fed 
ad libitum determined by Mclean and Mclean (90). 
The mortality was monitored for one week before the surviving 
animals were killed by sodium brevital administration. 
4. STATISTICAL METHODS 
The effects of different levels and duration of feed 
restriction on the various drug metabolism parameters were analyzed 
utilizing the procedures available in GLM of SAS 1982 (91). For each 
drug metabolism parameter, differences among the treatment groups 
were evaluated using the analysis of variance. Significant parameters 
were tested for specific effects of level and duration of feed 
restriction to determine if the relationship was linear, quadratic or 
cubic. For those parameters where no significant effects of level 
and duration of feed restriction were observed among the treatment 
groups, the t-test was utilized to compare the mean of all treatment 
groups with the mean of the ad libitum group. A probability level of 
0. 05 or less was considered statistically significant. The least 
squares option was utilized to derive the group means and standard 
errors. 
In Experiments II and III, the Student ' s  t-test was utilized 
to determine significant differences between the two treatment means 
at the level of P < 0. 05. 
CHAPTER IV 
RES ULTS 
l .  EX PERIMENT I 
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The effects of different levels and duration of feed 
restriction were examined in 15 groups of healthy rats. On any 
parameter examined, when no significant effect of feed restriction 
was found among the 15 treatment groups, the mean of all the 
treatment groups was then compared with that of the ad libitum group 
of rats. It must be pointed out that the values reported for the 
treatment groups represented changes in the parameters primarily 
during the period of restriction. In the description of the analysis, 
a linear relationship denotes a straight line relationship between 
two variables (for example, a linear relationship between feed 
consumption and body weight gain means that for each unit increase or 
decrease in feed consumption, one can expect a proportional unit 
increase or decrease in the body weight gain in a straight line 
manner). A quadratic relationship simply denotes that the 
relationship is curvilinear (with one curvature or bend in the 
plotted line) whereas a cubic relationship denotes a curve with two 
bends in the plotted line, usually one concave and one con v ex much 
like the plot of a sine wave. 
When there is a significant effect of both the level and 
duration of feed restriction, a three dimensional graph is enployed 
to depict the response of the dependent variable (parameter). This 
response surface allows one to see the effects of both independent 
variables on the dependent variable at the same time. The equation 
for the response surface was derived using significant terms (P < 
0. 05) of the analysis as well as including those that would 
contribute to the significant terms (for example, if the quadratic 
duration by quadratic level interaction was significant, the other 
terms containing quadratic components of duration and level and all 
linear terms would also be included in the equation). 
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The total feed consumption data of these rats are presented 
in Table 3. The decrease in feed consumption with  increasing levels 
and duration of feed restriction was significant and follows an 
expected pat tern (Table 4). Upon statistical analysis of the data, 
the feed consumption of the restricted animals decreased in a 
significant linear manner with increasing levels and a quadratic 
manner with  the increasing duration of feed restriction. The 
significant quadratic duration by linear level interaction observed 
introduced a slight curvature on the duration side of the response 
surface (Figure 7). Thus, as the level of feed restriction increased, 
the total feed consumed decreased linearly and as the duration of 
feed restriction increased, the total feed consumed decreased 
curvilinearly. The equation for the response surface is as follows :  
Feed consumption (g) = 591. 94 - 46. 69 D - 2. 26 L + 0. 86 DL + 
7. 75 D2 - 0. 30 D2L 
where : D = duration of feed restriction 
TABLE 3 
FEED  CONSUMPT I ON 1 BY LEVEL  AN D DURAT I ON OF FE E D  RESTR I CT ION 
L ev e l  of res tr i ct i on Dur at i on of  res t r i c t i on (week s ) 
1 2 3 4 5 
:: : ��-:-: � : ;- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
( g )
- - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
0% 
1 5%  
30% 
45%  
522 . 3  + 10 . 3  500 . 3  + 1 0 . 3 - -
3 509 . 0  + 9 . 4  494 . 7  + 1 0 . 3 - -
46 7 . 5  + 10 . 3  454 . 3  + 10 . 4 
4 79 . 3  + 1 0 . 4 481 . 3  + 1 0 . 4 
448 . 0 + 1 1 . 74 4 1 9 . 6  + 1 0 . 3 - -
39 7 . 3  + 10 . 4 3 7 1 . 8  + 10 . 3  
1 Un l es s  ot herw i s e  s t at ed , each va l ue i s  the  LSMEAN + SEM of 5 an i ma l s .  
2 n = 1 7  an ima l s . 
3 n = 6 an i ma l s • 
4 n = 4 an i rn a 1 s • 
468 . 3 + 10 . 3  
385 . 7 + 10 . 4 
301 . 4 + 1 0 . 4 
0) 
........ 
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TABLE 4 
F VAL UE FROM THE ANAL YS I S  OF VARI ANCE FOR THE EFFECTS OF DI FFERENT L EVEL S 
AND DURATI ON OF FEE D  RESTRI CTI ON ON FE E D  CONSUMPTI ON, F INAL BO DY WE I GHT, 
WE I GHT GA IN AND L I VER WE I GHT 
Sourc e of v ariation df F V a lue 
feed fi n a l  body we i ght li ver 
consumption weight g ain weioht 
BLOCKS 9 21.981 6.981 5.501 10. 581 
DURATI ON 
1 i n e ar 1 31 7. 211 28.671 29.441 21. 721 
quadratic 1 1 .  02 0.22 0.67 1 .  03 
cubic 1 0.01 0.20 0.16 0.01 
LEVEL  
1 i near 1 19 3.491 40.461 44.681 151.901 
quadratic 1 2. 74 6.851 4.301 1 .  62 
DU RAT I ON X LEVEL  INTERACTIONS 
Duration x leve l  1 56.681 11.471 12.651 5.161 
Duration 2 x leve l  1 7.951 1.17 0.68 2. 75 
Duration x leve l 2 1 2.03 3.98 2.69 6.661 
D uration 2 x le v e l 2 1 0.15 4. 751 4.oo1 0.10 
Duration 3 x lev e l  1 0.36 2.08 0.90  3.93 
Duration 3 x leve l 2 1 0.9 2 o. 04 0.07 0.54 
1 P < o. 05. 
2Q uadratic fun ction. 
3cubic fun ction. 
527 
453 
:i 3 78 
304 
45 
Leve l  (% )  30 5 
1 Du ra t i on (weeks ) 1 5  
F i gure 7 . Feed con s umpt ion (FC ) of an ima l s a t  t he d i fferen t  l e ve l s  (L )  an d dura t ion (D J  
of feed res t r i ct ion . FC = 591 . 94 - 46 . 69 D - 2 . 26 L + 0 . 86 DL + 7 . 75 o2 -0. 30 D
2L (P < 0 . 05 ) .  
0) w 
and L = level of feed restriction (For the rest of this 
paper, duration and level in an equation will be 
denoted as D and L, respectively). 
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The data on final body weight, weight gain, feed consumption 
and liver weight are shown in Tables 5 through 7, respectively. Among 
the treatment groups, increasing levels and duration of feed 
restriction resulted in expected decreases in these four parameters. 
The decreases appeared to follow similar trends. Upon statistical 
analysis of the data, final body weight decreased in a significant 
curvilinear manner with increasing levels and duration of feed 
restriction (Table 4). In the analysis, highly significant linear 
components of duration and level effects on final body weight were 
observed as well as a significant quadratic component of the level 
effect. Significant interactions included linear duration by linear 
1 eve l and q uadr at i c duration by quadratic 1 eve 1 effects. The response 
surface is depicted in Figure 8 and the decrease in final body weight 
was greatest at the 45% level of feed restriction for five weeks. 
(Final body weight (g) = 164. 33 + 73. 15 D + 6. 97 L - 6. 46 DL - 14. 78 
D2 + 1. 27 D2L - 0. 13 L2 + 0. 11 DL2 - 0. 023 D2L2). 
As expected, the amount of body weight gain decreased as the 
level and duration of feed restriction increased (Table 5). This 
decrease was significantly affected by the increase in level and 
duration of feed restriction (Tab l e  4). The response surface was 
cur v il i near in both di rec t i on s of 1 eve 1 and du rat i on , w i th the 1 ea s t 
amount of body weight gain at 45% feed restriction for five weeks 
TABLE 5 
EFFECT OF D I FFERENT L E V ELS  AN D DURAT I ON OF FEED  RES TR I CT I ON ON F I NAL BODY WE I GHT ! 
L eve l  of res t r i c t i on Durat i on of res t r i c t i on (weeks ) 
2 3 4 
::: � :
-
�-:�:;
-
-
-
- - - -
- -
- -
- - -
-
-
-
- - - -
-
-
-
-
- - - - -
-
- - (
9
)
- -
-
-
- - -
- -
- - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
0% 
1 5%  
30% 
45% 
242 . 7 + 7 . 3 238 . 5  + 7 . 3 228 . 6  + 7 . 3 
238 . 7 + 6 . 7 3 229 . 9  + 7 . 3 21 8 . 6  + 8 . 3 
222 . 0 + 7 . 3 21 7 . 4  + 7 . 3 21 7 . 6  + 7 . 3  
1 un l es s  ot herw i s e  s t ated , each v a l ue i s  the LSMEAN + SEM of 5 an im a l s . 
2 n = 1 7  an i ma l s . 
3 n = 6 an i ma l s . 
4 n = 4 an i ma  l s . 
24 1 . 7 + 7 . 3  22 1 . 2  + 7 . 3 
4 224 . 1  + 7 . 3 2 2 7 . 5  + 7 . 3  
182 . 8  + 7 . 3 169 . 3  + 7 . 3 
0) 
U1 
TABLE 6 
EFFECT OF D I FFERENT L EVELS  AN D DURAT I ON OF FEED  RESTR I CT I ON ON BODY WE I GHT  GA I N 1 
L eve l of res t r i ct i on Durat i on of res t r i ct i on (wee k s ) 
0% 
15%  
30% 
45% 
- - - - - - - - - - - - - - - - - - - - -
2 3 4 5 
- - - - - - - - - - - - ( g ) -- - - - - - - - - - - - - - - -
2 160 . 5  + 3 . 8 
12 1 . 9  _:':: 7 . 2 140 . 1  + 7 . 2  140 . 1 + 7 . 2 1 30 . 0 + 7 . 2 141 . 0  + 7 . 2 
1 36 . 0  + 6 . 5 3 12 6 . 7 + 7 . 2 1 2 1 . 2  + 8 . 1 
1 22 . 2  + 7 . 2 1 1 2 . 8  + 7 . 2  1 1 8 . 6  + 7 . 2 
1 un l e s s  ot herwi s e  s t ated , each v a l ue i s  the LSMEAN + SEM of 5 an im a l s . 
2 n = 1 7  an i ma  l s • 
3 n = 6 an i ma  l s . 
4 n = 4 an i rn a l  s • 
4 1 1 8 . 8 + 7 . 2 
81 . 1  + 7 .  2 
12 3 . 1 � 7 . 2  
68 . 2  + 7 . 2 
0) 
0) 
0\ 
u, 
TABLE 7 
EFFECT OF DI FFE RENT  LE VEL S AN D DURAT I ON OF FEE D  RESTR I CT I ON ON L I VE R  WE I GHT 1 
L ev e l  of res tr i c t i on Durat i on of res t r i c t i on (wee k s ) 
1 2 3 4 5 
::�:-:-:� ::;
-
-
-
-
-
-
-
-
-
- -
- - -
-
-
-
-
-
- - -
-
-
-
-
-
- - -
- -
- (
9
)
-
- -
- - -
-
- - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
0% 
1 5%  
30% 
45 % 
8 . 3 + 0 . 28 7 . 7 + 0 . 28 7 . 6  + 0 . 28 
6 .  9 + 0 .  25 3 7 . 1 + 0 . 28 6 . 9  + 0 . 32 
6 . 2 + 0 . 28 6 . 4  + 0 . 28 6 . 0  + 0 . 28 
1 Un l es s  ot he rw i s e  stated , each v a l ue i s  the LSMEAN + SEM of 5 an ima l s .  
2 n = 1 7 an ima l s .  
3 n = 6 an ima l s . 
4 n = 4 an i ma l s .  
7 . 7 + 0 . 28 7 . 3  + 0 . 28 
4 6 . 7 + 0 . 28 4 6 . 8  + 0 . 28 
5 . 2  + 0 . 28 4 . 8  + 0 . 28 
0\ 
-......J 
243 
- 2 16 
1 90 LL 
163 , .... 
45  
Level ( % )  30 
1 
1 5  
5 
4 
2 Du rati on ( weeks)  
F i gure 8. The effect of di fferent l eve l s  (L ) and duration (D ) of fe ed restr i ction on f i na l  
body weight (FBW ). FBW = 164. 33 + 73. 15 D + 6. 97 L - 6. 46 DL - 14. 78 o2 + 
1. 27 D2L - 0. 13 L 2 + 0. 11 DL 2 - 0. 02 D2L 2 (P < 0. 05 ). 
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(Body weight gain (g) = 63. 60 + 74. 28 D + 6. 52 L - 6. 16 DL - 14. 34 o2 
+ 1. 17 o2L - 0. 12 L2 + 0. 10 DL2 - 0. 021 o2L2) (Figure 9). 
The decrease in liver weight al so fol l owed a pattern very 
simi l ar to that of body weight gain (Tab l e  7). The pattern of 
decrease with increasing l evel s and duration of feed restriction was 
significant (Tab l e  4). Liver weight decreased curvi linear l y  as the 
l eve l of feed restriction increased, and linear l y  as the duration of 
feed restriction increased (Figure 10). The l owest l iver weight was 
observed at the highest l eve l s and duration of feed restriction 
(Liver weight (g) = 10. 59 - 0. 76 D - 0. 19 L + 0. 054 DL + 0. 0024 L2 -
2 0. 001 DL ) . 
Increasing l eve l s and duration of feed restriction did not 
a l ter the hepatic microsomal protein content in any specific pattern 
when expressed as per gram of wet l iver tissue (Tab l e  8). Thus, the 
mean hepatic microsoma l protein content of the 15 treatment (feed 
restricted) groups were compared with that of the rats in the ad 
l ibitum group. The feed restricted rats had significantl y  higher mean 
hepatic microsoma l protein content than the ad l ibitum contro l s  (16. 9 
� 0. 25 vs 15. 6 � 0. 40 mg/g liver, respectivel y) (Figure 11). When 
this protein is expressed as total hepatic content, a genera l 
decreasing pattern was observed with increasing l eve l s and duration 
of feed restriction (Tab l e  9). Upon statistica l ana l ysis, onl y  the 
l inear l eve l effect was significant (Tab l e  10). Thus, it appears that 
tota l hepatic microsoma l protein decreased linear l y  as the l evel of 
feed restriction increased (Tota l hepatic microsomal protein (mg) = 
143. 95 - 1. 02 L) (Figure 12). 
1 40 
1 1 1 
:::: 82 
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45 
Leve l ( % )  30 
1 
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3 
Du ra t i on (weeks ) 
4 
5 
F i gu re 9 . The effect of d i fferen t  l eve l s ( L ) an d durat ion ( D J of fe ed restr i c t ion on body 
we i ght ga i n  (WG ). WG = 63 . 60 + 74 . 28 D + 6 . 52 L - 6 . 16 DL - 14.34 o2 + 1 . 1 7 D2L - 0 . 12 L 2 + 0. 10  DL 2 - 0. 02 D2L 2 (P < 0 . 05 ) , 
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TABLE 8 
EFFECT OF DI FFE RENT LEVELS  AND DURAT I ON OF FEE D  RESTR I CT I ON ON HEPAT I C  MI CROSOMAL PROTE I N 1 
L eve l  of res tr i c t i on Durat i on of res t r i ct i on (wee k s ) 
2 3 4 5 
- - - - - - - - - - - - - - - - �- - - - - - - - - - - - - -
15 . 61 + o . 4 7 2 
- - - - - - - - - (mg/g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
0% 
15%  
30% 
45%  
15 . 90  + 0 . 9 0  18 . 2 7 + 0 . 90 15 . 00 + 0 . 90 
1 6 .  72 + 0 .  81 3 16 . 51 + 0 . 90 16 . 16 + 1 . 004 
1 6 . 69 + 0 . 90 1 7 . 19 + 0 . 90 1 7 . 36 + 0 . 90 
1 un l es s  ot herw i s e s t at ed , each v a l ue i s  t he  LSMEAN + SEM of 5 an i m a l s .  
2 n = 1 7  an i ma l s . 
3n = 6 an i r na l s .  
4n = 4 an ima l s .  
1 7 . 50 + 0 . 90 
1 7  . 32 + 0 . 90  
1 7 .  09 + 0 .  90  
15 . 76 + 0 . 90 
1 7 . 64 + 0 . 90 
18 . 04 + 0 . 9 0  
""'-J 
N 
18 
n = 75 
17  
s::::: 16 n 
= 1 7  ..... 
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Figure 11 . Hepa tic microsoma l protein conte n t  of ad libitum 
v s  feed res tri cted ra ts . Values are mean + SEM 
a nd are significan tly different  a t  P � 0 . 05. 
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TABLE 9 
EFFE CT OF DI FFERENT LEVELS  AN D DURAT I ON OF FEED  RESTR I CT I ON ON TOTAL HE PAT I C  M I CROSOMAL PROTE I N 1 
L eve l of res tr i ct i on Durat i on of  res t r i ct i on (week s ) 
0% 
1 5%  
30% 
45% 
2 3 4 5 
--
-
- - -
- --
-
-
-
- -
- -
- -
' - - -
-
- - - -
- - -
-
-
- - - - -
- - - -
- - -
-
-
(
m g ) -
- - - - -
-
-
-
-
-
- -
- - -
- - - - -
-
- - - - -
- - -
- -
-
- - -
- -
- - - -
-
160 . 21 + 4 . 1 5 2 
1 30 . 63 + 7 . 86 14 1 . 99 + 7 . 85 1 1 3 . 14 + 7 . 88 1 3 5 . 08 + 7 . 87 1 1 4 . 62 + 7 . 88 - - - - -
1 14 . 19 + 7 . 1 3 3 1 16 . 78 + 7 . 84 1 1 0 . 92 + 8 . 854 1 1 6 . 20 + 7 . 85 1 1 7 . 9 7  + 7 . 8 7 
102 . 59 + 7 . 85 109 . 24 + 7 . 88 103 . 88 + 7 . 87 87 . 35 + 7 .  86 86 . 48 + 7 . 87 
1 un l es s  ot herw i s e s t ated , each v a l ue i s  t he  LSMEAN + SEM of 5 an i ma l s .  
2 n = 1 7  an i rn a l s • 
3 n = 6 an i in a 1 s • 
4 n = 4 an i ma l s • 
'-..I 
+::a 
75 
TABLE 10 
F VALUE FROM THE ANALYSIS OF VARIANCE FOR THE EFFECTS OF D I FFERENT 
LEVELS AND DURAT ION OF FEED RESTRICTION ON HEPATIC CYTOCHROME P-450 
(P450), TOTAL MICROSOMAL AND 100, 000 X g SUPERNATANT (SN) PROTEINS 
Source of variation df F Va l ue 
Microsomal 100, QQQ X g 
Protein SN Protein P450 
BLOCKS 9 1. 29 5. 02 1 4. 63 1 
DURATION 
1 3. 83 1 l inear 1 3. 89 0. 68 
quadratic 1 0. 45 0. 03 0. 00 
cubic 1 0. 30 0. 67 0. 30 
LEVEL 
34. 70 1 66. 71 1 7. 96 1 linear 1 
quadratic 1 0. 55 l .  38 0. 44 
DU RAT ION X LEVEL INTERACTIONS 
Duration x l eve 1 1 0. 37 4. 63 1 0. 02 
Duration2 x l evel 1 0. 16 0. 94 0. 07 
Duration x l evel 2 2. 66 0. 1 3 0. 28 
Duration2 x l evel 2 1 0. 32 0. 07 1. 99 
Duration3 x l evel 1 1. 10 4. 34 1 0. 43 
Duration3 x l evel 2 1 0. 1 3 1. 83 1. 72 
1 P < o .  05. 
2Quadrat i c function. 
3cubic function. 
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Figure 12 .  The effect of d i ffere n t  l eve l s (L ) of feed  res tr i ct i o n  
on tota l hepat ic  mi crosoma l  prote i n  ( TMP ) . 
TMP = 143 . 95 - 1 . 02 L ( P S 0 . 05 ) . e n = 25 . 
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The hepatic protein content of 100,000 x g SN (expressed as 
per gram of wet liver tissue) remained basically unaltered by feed 
restriction (Table 11). However, when this was expressed as the total 
hepatic protein content, a general pattern of decreasing hepatic 
100, 000 x g SN protein evolved with increasing levels and duration of 
feed restriction (Table 12). This decrease was significantly affected 
by the level as well as the duration of feed restriction (Table 10). 
The response surface included a significant cubic function of the 
duration effect and at the lower level of feed restriction there was 
a lack of a consistent pattern for the changes (Figure 13) (Total 
100,000 x g SN (mg) = 1380. 14 - 760. 64 D - 20. 67 L + 21. 30 DL + 
277. 77 o2 - 8. oo o2L - 29. 58 o3 + o. 84 o3L). 
The hepatic cytochrome P-450 content (nmoles/g liver) 
increasd with increasing levels and duration of feed restriction 
(Table 13). However, only the effect of the level of restriction was 
statistically significant (Table 10). The increase in the hepatic 
cytochrome P-450 content was linear with the increase in the level of 
feed restriction as shown in Figure 14 (Hepatic cytochrome P-450 
content (nmoles/g liver) = 14. 36 + 0. 05 L). 
The in vitro hepatic NADPH cytochrome c reductase activity 
(pmoles cytochrome c reduced/min/g liver), on the other hand, 
remained unaltered by the effects of different levels and duration of 
feed restriction (Table 14). However, the mean activity of the 
hepatic cytochrome c reductase in the feed restricted group (taken 
together) was significantly lower than that in the ad libitum group 
TABLE 1 1 
EFFE CT OF DIFFERENT LEVELS AND DURAT I ON OF FEED  RESTR I CT I ON ON HEPAT I C  100 , 000 x g SUPERNATANT (S N ) PROTE I N 1 
L eve l of res tr i ct i on Durat i on of restr i ct i on (wee k s ) 
0% 
15% 
30% 
45% 
2 3 4 5 
:���
-
:
-
�� : :;
- - - -
-
- - - - - - - - - - - - - - - - -
-
- - - - - ( mg/ g l i ver )
- - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
91 . 88 + 4 . 02 88 . 79 + 4 . 02 
9 7 . 58 + 3 . 65 3 94 . 73 + 4 . 01 - -
94 . 09 + 4 . 02 89 . 5 7 + 4 . 03 
89 . 7 7 + 4 . 03 98 . 98 + 4 . 03 
89 . 39 + 4 . 53 4 90 . 84 + 4 . 01 
89 . 09 + 4 . 03 90 . 61  + 4 . 02 
1 un l ess  ot herw i s e  s tated , each v a l ue i s  the LSMEAN + SEM of 5 an ima l s . 
2n = 1 7 an ima l s . 
3n = 6 an ima 1 s . 
4 n = 4 an i ma 1 s . 
9 2 . 08 + 4 . 03 
89 . 28 + 4 .  03 
88 . 45 + 4 . 03 
-.....J 
(X) 
TABLE 1 2  
EFFECT OF DI FFERENT L E V ELS  AN D DURAT I ON OF FE E D  RESTR I CT I ON ON  TOTAL 100 , 000 x g SUPERNATANT  
(
SN
) 
PROTE I N 1 
Leve l of res tr i ct i on Durat i on of res tr i ct i on 
(
week s
) 
0% 
1 5%  
30% 
45%  
2 3 4 5 
- - - - - - - - - - - - - - - - l- - - - - - - - - - - - - - - - - - - - - - - - - - - - (mg ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
924 . 66 + 20 . 9 2 2 
762 . 5 7 + 39 . 56 690 . 35 + 39 . 54 682 . 00 + 39 . 67 766 . 64 + 39 . 66 670 . 38 + 39 . 67 - -
66 7 . 2 1  � 35 . 89
3 668 . 71 � 39 . 51 61 8 . 15 � 44 . 55
4 604 . 31 � 39 . 5 1 605 . 1 6 + 39 . 62 
5 7 3 . 4 2  + 39 . 54 5 70 . 69 + 39 . 67 525 . 20 + 39 . 66 4 70 . 10 + 39 . 56 4 14 . 05 + 39 . 66 - -
1 un l es s  otherw i s e  stat ed , each va l ue i s  the LSMEAN + SEM of 5 an ima l s . 
2 n = 17 an i ma 1 s . 
3 n = 6 an i ma l s . 
4 n = 4 an i ma l s . 
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Figure 13. The effect of different l eve l s (L) and duration (D) of feed restriction on tota l  
100,000 x g supernatant proteins (TSNP). TSNP = 1380. 14 - 760. 64 D - 20. 67  L + 
21. 30 DL + 27 7. 77  o2 - 8. 00 D2L - 29. 58 o3 + 0. 84 03L (P < 0. 05). 
00 
0 
TABLE 1 3  
EFFECT OF DI FFERENT LEV E LS  AN D DURAT I ON OF FEED  RESTR I CT I ON ON HEPAT I C  CYTOCHROME  P -450 CONTENT 1 
L ev e l  of res t r i c t i on Durat i on of res t r i ct i on (week s ) 
0% 
1 5%  
30% 
45% 
2 3 
::�:-
�
-
��::;
- - - - - - - - - - - - - - - - - - - - - - - - - ( nmo l es / g l i ver ) - - - - - - -
14 . 1  + 0 . 82 16 . 1  + 0 . 81 14 . 3  + 0 . 82 
16 . 8  + 0 . 74 3 1 5 . 4  + 0 . 81 1 5 . 2  + 0 . 9 2 
16 . 1  + 0 . 81 1 6 . 7 + 0 . 82 16 . 8  + 82 
1 Un l es s  ot herw i s e  st at ed , eac h va l ue i s  the LSMEAN + SEM of 5 an ima l s .  
2 n = 17  an i ma l s • 
3 n = 6 an i ma  l s . 
4 n = 4 an i m a l s .  
4 
4 5 
- - - - - - - - - - - - - - - - - - - - - - - -- - - - - - -
1 5 . 6  + 0 . 82 
1 6 . 9  + 0 . 9 2 4 
1 7 . 4  + 0 . 82 
1 5 . 1 + 0 . 82 
16 . 3  + 0 . 82 
16 . 6  + 0 . 82 
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Figure 14 . The  effect  of d i ffere n t  l eve l s ( L )  of feed res tri ct i o n  
o n  hepa ti c  cytochrome P-450 conten t  ( 450 ) . 
P-450 = 14 . 36 + 0 . 05 L ( P �0 . 05 ) . e n = 25 . 
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TABLE 14 
EFFECT OF D I FFERENT LEVELS AN D DURAT I ON OF FEED  RESTR I CT ION ON 1THE IN  V I TRO  ACT I V IT I ES OF HE PAT I C  NADPH CYTOCHROME C RE DUCTASE 
L eve l of res tr i ct i on Durat i on of res t r i ct i on (week s ) 
0% 
15% 
30% 
45% 
2 3 4 5 
- - - - - -- - - - - - - - - - - - - - - - - (pmo l es cyt ochrome c red uced/m i n / g  l i ve r ) - - - - - - - - - - - - - - - - - - - - - - - - - - - -
2 3 . 56 + 0 . 1 3  
2 .  6 6  + 0 .  24 
3 2 . 68 + 0 . 22 
2 .  54 + o .  24 
2 . 88 + 0 . 24 
2 .  89 + 0 .  24 
2 . 83 + 0 . 24 
2 .  99 + 0 .  24 
4 2 . 45 + 0 . 2 7  
2 .  76  + 0 .  24 
1 Un l es s  ot herw i s e  s t at ed , each va l ue i s  the LSMEAN + SEM of 5 an i ma l s .  
2 n = 17  an ima l s .  
3 n = 6 an i m a  l s • 
4 n = 4 an i rn al s • 
2 .  77  + 0 .  24 
2 .  75 + 0 .  24 
2 . 88 + 0 .  24 
2 . 73 + 0 . 24 
2 . 96 + 0 . 24 
3 . 30 + 0 . 24 
co 
w 
84 
(Figure 15) (2. 8 .±. 0. 06 vs 3.6 .±_ 0. 15 µmoles of cytochrome c 
reduced/min/g liver, respectively). 
The in vitro activities of hepatic aniline hydroxylase 
increased with increasing levels and duration of feed restriction 
(Table 15). Statistical analysis of the data revealed that this 
increase was linear with the increase in both parameters of 
restriction (Table 16). This linear response surface is presented in 
Figure 16 and the highest effect on the in vitro enzymatic activity 
was observed at 45% feed restriction for five weeks (aniline 
hydroxylase activity (nmoles of HCHO formed/min/g liver) = 5. 90 + 
0. 81 D + 0. 14 L). 
The in vitro activities of hepatic PCMA-N-demethylase (nmoles 
of PCA formed/min/g liver) and p-nitrophenol UDP-glucuronyl 
transferase (nmoles of p-nitrophenol conjugated/min/g liver) are 
presented in Tables 17 and 18, respectively. Feed restriction did not 
alter significantly the in vitro activities of these two enzymes when 
expressed as per gram of wet liver tissue (Table 16). 
The in vitro activity of hepatic glucose-6-phosphate 
dehydrogenase increased with increasing levels and duration of feed 
restriction (Table 19). The highest in vitro activity of hepatic 
glucose-6-phosphate dehydrogenase was observed at the 45% restriction 
for five weeks. However, only the duration of feed restriction was 
found to be statistically significant (Table 20). This significant 
increase in glucose-6-phosphate dehydrogenase activity over the 
increase in duration of feed restriction was linear and is shown in 
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Figure 15 .  Hepatic cytochrome c reducta se a ctiv i ty of ad l ib i tum 
vs feed res tr i c ted rats . Va l ues  a re mea n + SEM a nd  
a re significant l y differe n t  a t  P � 0 . 05 .  
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TABLE 1 5  
EFFECT OF  D I FFE RENT LEVELS AN D DURAT I ON OF  FEED  RE STR I CT I� ON TH E  IN  V I TRO  ACT I V IT I ES  OF  HE PAT I C  AN I L I N E  
H YOROX YLAS E  
L ev e l  o f  res t r i ct i on Dur at i on of res t r i ct i on (weeks ) 
0% 
1 5%  
30% 
45% 
1 2 3 4 5 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - ( nmo l es HCHO formed/m i n / g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
2 10 . l  + 0. 4 7  
8 . 7 + 0 . 89 10 . 3 + o .  89 8 . 6 + 0 . 90  
1 1 . 7 + 0 . 81 3 12 . 5  + 0 . 89 1 1 . 8 + 1 .  01 
12 . 3  + 0 . 89 13 . 4  + 0 . 90 14 . 2  + 0 . 89 
1 Un l es s  ot herw i s e  s t at ed , each v a l ue i s  the LSMEAN + SEM of 5 an i ma l s . 
2 n = 17 an ima l s .  
3 n = 6 an i ma l s • 
4 n = 4 an i ma  l s . 
12 . 8  + 0 . 89 
4 14 . 0  + 0 . 89 
14 . 8  + 0 . 89 
1 1 . 2 + 0 . 90 
14 . 3  + 0 . 89 
16 . 3  + 0 . 89 
0) 
O"I 
TABLE 16 
F VAL UE FROM THE ANALYS I S  OF VAR I ANCE FOR THE EFFECTS OF 
D I FFERENT LEVEL S AND DURAT ION OF FEED RESTRI CT ION ON THE IN 
VITRO ACT I VIT I ES OF HEPAT I C  AN I L I NE HYDROXYLASE ( AH) , 
PCMA-N-DEMETHYLASE ( PCMAD) AND UDP-GL UCURONYL TRANSFERASE 
( GT) 
Source variation df F Value 
AH PCMAD GT 
BLOCKS 9 2. 94 1 5. 24 1 4.901 
DURAT ION 
linear 1 20. 1 3 1 0.30 0. 18 
quadratic 1 0.10 0.00 0.51 
cubic 1 0.09 1. 04 0.33  
LEVEL 
linear 1 34. 74 1 0.38 0.02 
quadratic 1 1. 73 0.02 0.00 
DURAT ION x LEVEL INTERACT IONS 
Duration x le vel 1 0.30 0.1 3 1.47 
Duration 2 x le vel 1 0. 01 0.16 0.05 
Duration x l e ve l 2 1 0 . 10 1 .  05 1 . 4 2 
Duration 2 x level2 1 0. 04 0. 98 0.53 
Duration 3 x level 1 0.88 0.80 0.07 
Duration 3 x le vel2 1 0.00 1. 14 0.00 
1 P < o .  05. 
2ouadratic function. 
3cubic function. 
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Figure 16. The effect of different l eve l s (L) and duration (D) of feed res triction on the 
in vitro activities of hepatic ani line hydroxyl as e  (AH). AH = 5. 90 + 0. 81 D + 
0. 14 L (P i 0. 05). Activity = nmol es HCHO formed/min. 
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TABLE 1 7  
EFFECT OF DI FFERENT LEVEL S AN D DURAT I ON OF FEE D RE STR I CT I 2N ON THE I N  V I TRO ACT I V I T I ES OF HEPAT I C  
PCMA-N - DEMETHYLASE  
L eve l of  res tr i c t i on Dur at i on of res t r i ct i on (weeks ) 
0% 
1 5%  
30% 
45 % 
0 1 2 3 4 5 
- - - - - --- - - - - - - - - - - - - - - - - - - - - ( nmo l es PCA formed/m i n / g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
2 22 . 7  + 1 . 4  
20 . 7 + 2 .  7 
3 23 . 0  + 2 . 5  
19 . 7  + 2 . 7 
21 . 0 + 2 .  7 
24 . 5  + 2 . 7 
18 . 9  + 2 . 7 
2 7 . 8  + 2 . 7 
4 20 . 3  + 3 . 1 
21 . 4 + 2 .  7 
1 Un l es s  ot herw i s e  stat ed , each v a l ue i s  the  LSMEAN + SEM of 5 an i m a l s . 
2 n = 17  an i rn a 1 s • 
3 n = 6 an i ma 1 s • 
4 n = 4 an ima l s .  
19 . 7 + 2 .  7 
18 . 8  + 2 . 7 
22 . 3  + 2 . 7 
23 . 8  + 2 . 7 
2 2 . 7 + 2 . 7 
21 . 8 + 2 .  7 
(X) 
I..O 
TABLE 18  
EFFECT OF  D I FFERENT LEVELS  AND DURAT I ON OF  FEE D  RESTR I CT I ON 0� THE  I N  V ITRO ACT I V I T I ES  OF  HE PATI C UDP -GL UCURONYL  
TRAN SF  E RASE 
L ev e l  of res tr i ct i on Durat i on of res t r i ct i on (week s ) 
0% 
15% 
30% 
45% 
1 2 3 4 5 
--- - - - - - -- - - - - - - - - - - - - ( nmo l es p-n i t r ophen o l  con j uga t ed/m i n / g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - -
55 . 60 + 3 . 51 2 
55 . 31 + 6 . 37 62 . 79 + 6 . 38 - -
45 . 04 + 5 . 79 3 52 . 7 7 + 6 . 37 - -
49 . 01 + 6 . 38 50 . 82 + 6 . 40 
45 . 1 7 + 6 . 40 52 . 1 7 + 6 . 40 44 . 44 + 6 . 40 - -
55 . 9 2 + 7 . 194 51 . 7 1  + 6 . 37 53 . 2 1 + 8 . 39 
50 . 49 + 6 . 40 50 . 26 + 7 . 204 51 . 53 + 6 . 40 
1 un l es s  otherw i s e s t at ed , each v a l ue i s  the  LSMEAN + SEM of 5 an i m a l s .  
2 n = 16 an i ma  l s . 
3 n = 6 an i ma 1 s • 
4 n = 4 an i ma l s • 
I..O 
0 
TABLE 19 
EFFE CT OF DI FFERENT LEV ELS  AN D DURAT I ON OF FE ED  RESTR I CT I ON ON T� I N  V ITRO ACT I V IT I E S  OF HE PAT I C  
GL UCOSE -6-PHOSPHATE DEH Y DROGENASE 
L eve l s of res tr i ct i on Dur at i on of rest r i ct i on (weeks ) 
0 2 3 4 5 
0% 
15% 
30% 
45% 
---- - - - - - - -
2
- - - - - - - - - - - - - - - (jJmo l es NADPH formed/mi n / g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
1 . 10 + 0. 2 1  
1 .  09  + 0 .  40 
3 1 .  71 + 0 .  36 
1 . 68 + 0 . 40 
2 . 4 3 + 0 . 40 
2 . 49 + 0 . 40 
1 .  80 + 0 .  40 
1 .  35 + 0 . 40 
4 2 . 07 + 0 . 45 
2 . 12 + 0 . 40 
1 un l es s  otherw i s e  s t ated , each v a l ue i s  the LSMEAN + SEM of 5 an i ma l s .  
2 n = 17 an ima l s .  
3 n = 6 an i ma 1 s .  
4 n = 4 an i rn a 1 s • 
2 .  79 + o .  40 
2 . 78 + 0 . 40 
3 . 4 7 + 0 . 40 
2 . 35 + 0 . 40 
2 . 50 + 0 . 40 
3 . 1 2  + 0 . 40 
I..O ....... 
TABLE 20 
F VAL UE FROM THE ANAL YSIS OF VAR IANCE FOR THE EFFECTS OF 
DIFFERENT LEVELS AN D DURAT ION OF FEED RESTR ICT ION ON THE IN 
VITRO ACT IVIT IES OF HEPAT IC GL UCOSE-6-PHOSPHATE 
DEH Y DROX YGENASE (G6PD), 6-PHOSPHOGL UCONATE DEH Y DROGEN ASE 
(6PGD) AN D MAL IC EN ZYME (ME) 
Source of variation df F Val ue 
G6PD  6PGD ME 
BLOCKS 9 1. 32 6. 68 1 3. 77 1 
DURAT ION 
l in ear 1 15. 04 1 0. 28 14. 2 1 1 
quadratic 1 0. 37 1 .84 0. 58 
cubic 1 0. 2 2  0. 91 0.68 
LEVEL 
linear 1 1. 97 8. 54 1 0.06 
quadratic 1 0. 13 1. 54 4.67 1 
DURAT ION x LEVEL INTERACT ION S  
Duration x l eve 1 1 0.86 0.05 0.03 
Duration 2 x level 1 0. 18 0. 25 1. 00 
Duration x level2 1 0. 95 10. 80 1 1. 74 
Duration 2 x level2 1 0 . 39 o .  01 0 . 07 
Durat i on3 x 1 evel 1 1. 46 0.03 0.00 
Duration 3 x level 2 1 0. 29 0. 19 1. 10 
1 P < o .  05. 
2Quadratic function. 
3cubic function. 
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Figure 17 (G l ucose-6-phosphate dehydrogenase activity (µmo l es NADPH 
formed/min/g liver) = 1. 32 + 0. 31 D). 
The data for the in vitro activity of hepatic 
6-phosphog l uconate dehydrogenase (fmo l es NA DPH formed/min/g liver) is 
presented in Tab l e  21. The activity was al tered by the l evel as we l l 
as duration of feed restriction. At the 15% and 45% l eve l s of feed 
restriction, the 6-phosphog l uconate dehydrogenase activity increased 
with increasing duration of feed restriction whi l e  at the 30% l evel , 
the activity decreased with increasing duration of feed restriction. 
Concurrentl y, the activity al so decreased with increasing l evel s of 
feed restriction in a curvi l inear manner. T his is represented by the 
response surface in Figure 18 (6-phosphog l uconate dehydrogenase 
activity (µmo l es of NADPH formed/min/g liver) = 1. 204 + 0. 873 D + 
0. 220 L - 0. 067 DL - 0. 00388 L2 + 0. 00111 DL2). 
The in vitro activity of hepatic ma l ic enzyme (µmo l es NA DPH 
formed/min/g liver) a l so increased with increasing l eve l s and 
duration of feed restriction (Tab l e  22). This increase was 
significantl y  l inear and curvi l inear with increasing duration, and 
l evel s of feed restriction, respectivel y  (Tab l e  20). The response is 
presented in Figure 19 and the duration of feed restriction exerted a 
greater effect on the enzyme activity than the l evel of feed 
restriction (hepatic ma l ic enzyme activity (µmo l es NA DPH formed/min/g 
liver) = 0. 258 + 0. 103 D + 0. 047 L - 0. 0008 L2). 
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Figure 17 . The effect of the  duration ( D )  of feed res triction on 
g l ucose-6-phosphate dehydrogenase  ( G6PD ) . G6PD = 1 . 32 + 
0 . 3 1 D ( P  � 0 . 05 ) . e 
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TABLE 21 
EFFECT OF DI FFERENT LEVELS AN D DURAT I ON OF FEE D  RESTR I CT I ON ON T�E I N  V ITRO  ACT I V I T I E S OF HE PAT I C  
6- PHOSPHOGL UCONATE DEH Y DROGENASE 
L eve l of res t r i c t i on Durat i on of  res t r i ct i on (weeks ) 
0% 
15%  
30% 
45% 
1 2 3 4 5 
- - - - - - - - - - - - - -� - - - - - - - - - - - - 9-1mo l es NADPH formed/m i n / g  l i ver ) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
2 4 . 05 + 0 . 1 1  
3 . 76 + 0 . 20 
3 4 . 25 + 0 . 19 
3 . 50 + 0 . 20 
3 . 86 + 0 . 20 
4 . 09 + 0 .  20 
3 . 30 + 0 . 21 
3 . 78 + 0 . 21 
4 3 . 5 7 + 0 . 23 
3 . 42 + 0 . 21 
1 Un l es s  ot herw i s e  s t ated , each v a l ue is the LSMEAN + SEM of 5 an i m a l s .  
2 n = 17  an ima l s .  
3 n = 6 an i ma l s . 
4 n = 4 an ima l s .  
4 . 23 + 0 . 21 
3 . 80 + 0 . 20 
3 . 68 + 0 . 20 
4 . 14 + 0 . 2 1  
3 . 59 + 0 . 20 
3 . 75 + 0 . 2 1  
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Figure 18. The effect of different l eve l s (L) and duration (D) of feed restriction on the 
in vitro activities of hepatic 6-phosphog l uconate dehydrogenase (6PGD). 
6PGD = 1.204 + 0.873 D + 0.220 L - 0.067 DL - 0.004 L2 + 0.001 DL2 
(P � 0.05). Activity = fmol es of NADPH formed/min. 
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TABLE 22 
EFFE CT OF D I FFE RENT LEVELS AND DURAT I ON OF FEE D RE STR I CT I ON ON THE IN  V I TRO  ACT I V I T I ES OF HE PAT I C  MAL I C  ENZ YME 1 
L ev e l  of res tr i ct i on Dur at i on of res t r i ct i on ( week s ) 
0% 
1 5% 
30% 
45% 
1 2 3 4 5 
- - - - - - - - - - - - - - - - - - - - - - - - - - - (pmo l es NADPH formed/m i n / g  l i ver ) - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - -
2 0 . 91 + 0 . 07 
O .J3 � 0 . 14 
3 
1 . 1 3 + 0 . 1 3  
0 . 90 + 0 . 14 
1 . 14 + 0 . 14 
1 . 40 + 0 . 14 
0 . 9 2  + 0 . 14 
o .  87 + 0 . 14 
4 1 .  05 + 0 . 16 
1 . 04 + 0 . 14 
1 Un l es s  ot herw i s e  s t at ed , each v a l ue i n  the  LSMEAN + SEM of 5 an i ma l s .  
2 n = 1 7  an ima l s .  
3 n = 6 an i ma l s . 
4 n = 4 an ima l s .  
1 .  40 + 0 . 14 
1 .  23 + 0 . 14 
1 . 14 + 0 . 14 
1 . 27 + 0 . 14 
1 . 45  + 0 . 14 
1 .  41 + 0 . 14 
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Figure 19. The effect of different leve l s  (L) and duration (D) of feed restriction on the 
in vitro activities of hepatic ma lic enzyme (ME). ME = 0. 258 + 0. 103 D + 
0. 047 L - 0. 0008 L2 (P .s_ 0. 05). Activity = 11mol es NADPH formed/min. 
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2. EXPERIMENT II 
This study was carried out to further substantiate the 
effects of feed restriction on the activities of the hepatic enzymes 
examined in Experiment I by determining the in vivo metabolism of a 
drug that is metabolized by the mixed function oxidase system. From 
the results in Experiment I, the changes in the in vitro activities 
of the enzymes examined were not following any consistent patterns at 
the lower levels and duration of feed restriction. The effect of feed 
restriction on these enzymes was most marked after four weeks of the 
45% level of restriction. 
In this experiment, the treatment group of rats were thus 
feed restricted at 45% for four weeks before being dosed with the 
antipyrine (40 mg/kg body weight). The body weight and feed 
consumption data are presented in Table 23. The feed restricted group 
of animals had lower body weights (35%) and weight gain (52%) than 
the ad libitum animals. As shown in Table 24, the apparent volume of 
distribution of antipyrine in the 45% feed restricted rats was 
approximately 46% less when compared to the ad libitum rats. The 
blood clearance was 39% less while the blood half life was 11% less 
in the 45% feed restricted rats when compared to the ad libitum 
controls. All the decreases in these parameters are significant at P 
< 0. 05. 
3. EXPER IMENT III 
In this experiment, the animals were the same animals that 
were used for the antipyrine experiment. They were allowed to recover 
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TABLE 23 
EFFECT OF 45% FEED RESTRICTION FOR FOUR WEE� ON FINAL BODY  WEIGHTS
1 
AND FEED CONSUMPTION 
Parameter Ad 1 i bi tum 45% restricted 
Initial body weight (g) 1 1 7 . 2 + 1 . 60 12 1 . 3  + 1 . 9 1 
Fina 1 body weight (g) 271 . 9  + 4 . 81 195 . 3  + 2 . 5 5 2 
Weight gain (g) 154 . 7  + 4 . 01 74 . 0  + 3 . 02 2 
Feed consumption ( g) 444 . 5  + 49 . 94 2 79 . 3 + 4 • 63 2 
1Each val ue is the mean + SEM of 9 rats per group . 
2statistically significant at P < 0 . 05 .  
TABLE 24 
EFFECT OF 45% FEED RESTRICTION FOR FOUR WEEKS ON THE METABOLISM 
OF ANTI PY RINE 
Parameter ad 1 i bitum 45% restricted 
Vol ume of distribution (ml) 1 44 . 64 + 14 . 90 1 78 . 21 + 3 .  49 2 
Blood clearance (ml /min) 1 . 9 2 + 0 .  24 1 . 1 7 + o .  09 2 
Blood half life (min) 53 . 00 + 1 . 75 47 . 22 + 1 . 9 1 2 
1val ues are mean + SEM. of 9 rats per group. 
2Significantly different from the ad lib group (P < 0 . 05 ) .  
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from any possible effects of the antipyrine study for approximately 
36 - 42 days before the toxicity of the LD50 (5. 4 mg/kg body weight) 
dose of carbon tetrachloride was examined. The data on mortality, 
body weight and liver weight are presented in Table 25. As expected 
the 45% feed restricted rats had significantly lower mean body 
weights at the time of drug administration and at death. The mean 
liver weight was also lower although this is not statistically 
significant. However, the liver as a percentage of body weight at 
death was significantly higher. The mortality at the 5. 4 mg/kg dose 
of carbon tetrach loride were seven out of ten and four out of five 
for the ad libitum and 45% feed restricted groups respectively. At 
the end of one week after carbon tetrachloride administration, the 
three surviving rats in the ad libitum group had resumed feeding and 
did not show any morbidity. The one surviving rat in the 45% feed 
restricted group on the other hand was still off feed, and the animal 
had a rough hair coat, nasa l exudates and was very lethargic. 
TABLE 25 
BODY WEIGHT , LIVER WEIGHT AND MORTALITY DATA OF THE AD LIBITUM VS 
45% FEED RESTRI CTED RATS DOSED WITH CARBON TETRACHLORIDE. 
Parameter 
No . of an i ma 1 s 
Body weight at time of dosage 
Mortality at 
5. 4 mg/kg body weight dose of 
carbon tetrachlor i de 
Body weight at time of death 
Liver weight 
Liver weight as % of 
body weight 
1 values are mean + SEM. 
Ad Li bit um 
10 
3 3 0 • 3 + 9 • 79 1 
7/10 
31 9. 3  + 8. 48 
13. 7 + 0. 36 
4. 3 + 0. 09 
2statistically significant at P < 0. 05. 
45% restricted 
5 
228. 0 + 8. 922 
4/5 
207. 2 + 9. 222 
1 1. 7 + 1. 04 
2 5. 7 + 0. 29 
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CHAPTER V 
DISCUSSION 
Numerous studies have been pub lished on the effects of 
starvation on in vivo and in vitro drug metabolism of drugs and 
chemica l s  (8-11, 65-71). It is genera l l y be l ieved that starvation 
resu lts in decreased drug metabol ism and decreased activities of drug 
metab lizing enzymes; however, much depends on the kind of substrate 
used. Inf l uenced by the increasing practice of food restriction in 
contemporary society, the effects of feed restriction was examined in 
an anima l model . It was found that 45% feed restriction for 28 days 
and 50% feed restriction for 49 days resu l ted in increased activities 
of certain drug metabol izing enzymes and this increase correl ated 
wel l with the increased in vivo metabol ism of hexobarbita l (14, 16). 
Thus it became important to further define the degree ( l eve l )  and the 
duration ( l ength of restriction period) of feed restriction needed to 
produce enhanced in vitro drug metabolizing enzyme activity, 
NADPH-generating enzyme activity and in vivo drug metabol ism as wel l 
as determine the pattern of these changes. 
1. GROWTH PARAMETERS 
Body weight changes 
Increasing l evel s and duration of feed restriction resu l ted 
in progressive curvi linear decreases in the amount of body weight 
gain and consequentl y  the fina l body weight of the anima l s  during the 
experimenta l period (Figure 8, page 68). The l ower weight gain was in 
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direct response to the reduced feed consumption of the rats and was 
most marked at the higher leve ls and duration of feed restriction. 
This lower body weight gain after a period of partial feed 
restriction observed is consistent with findings in the literature 
(13-16). At 45% feed restriction for four weeks, the lower body 
weight gain when compared with the ad libitum rats (49% less) in the 
current study is very simi l ar to that (54% less) in the study by 
Sachan (14). Starvation for one to three days has been also shown to 
progressively  decrease the fina l  body weight (9,67). However, it must 
be pointed out that during starvation, the decrease in weight which 
is rapid in the beginning is largely due to the loss of body water 
whi le tissue composition remains relativel y una ltered (7). The age of 
the animals  and/or the initial body weight are important 
considerations in comparing changes in the body weight. For example, 
in growing animals  the rate of gain wi l l  be the primary effect whi le 
in the adu lt and older anima ls, it wou ld be the l oss in the body 
weight. Further, the percent changes wi l l  be lesser in adu lts and 
older anima ls because of their initial body weight. On the basis of 
these results, it is possible to predict the body weight gain of rats 
by imposing a selected level of restriction and the duration of that 
restriction. For example, if the desired body weight for a wean ling 
Sprague Daw ley rat at the end of four weeks was 80 g, the level of 
restriction imposed shou ld be 45%. 
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Liver weight changes 
The changes in the liver weights were related to the changes 
in body weights (Figure 10, page 71). The liver weight expressed as a 
percent of the final body weight for the ad libitum group and the 45% 
feed restricted for 4 weeks (3. 9% and 2. 8% respectively) was very 
similar to that (4. 2% and 2. 9% respectively) by Sachan (14). Liver 
weight has also been reported to decrease progressively with the 
duration of starvation (9, 67, 92). For example, the liver weights 
expressed as a percent of final body weights in male Wistar rats 
starved for one to three days were 2. 4%, 2. 2% and 2. 1% respectively 
(67). The liver weight expressed as a percent of final body weight 
for the 45% feed restricted animals was a constant 2. 8%. Therefore, 
we could foreseeably predict the liver weight by determining the 
level and duration of feed restriction or by estimating from the body 
weight. For example, if a male weanling Sprague Dawley rat was feed 
restricted at 45% for 4 weeks, the liver weight should be 
approximately 2. 8% of the final body weight. However, one must be 
cautioned when making comparisons between liver sizes of ad libitum, 
starved and feed restricted animals in relation to liver function 
because of possible compositional differences even though the size 
may be the same. For example, in the ad libitum rats, the glycogen 
content would be expected to be much higher than that in starved or 
feed restricted rats. 
The 100, 000 x g supernatant protein content (mg/g liver) was 
not signficantly affected by the feed restriction (Table 11, page 
78). However, the total 100, 000 x g supernatant was significantly 
decreased as a result of the feed restriction (Figure 13, page 80) 
and th i s  again is more a reflection on the decrease in total liver 
size. 
2. IN VITRO DRUG METABOLISM PARAMETERS 
Hepatic microsomal proteins 
106 
The hepatic microsomal protein values when expressed per gram 
of wet liver tissue (Table 8, page 72) did not follow any consistent 
pattern at lower levels and shorter duration of feed restriction. 
This is indicative that at the lower levels and duration of the feed 
restriction, the animal ' s  adaptive mechanism may be attempting to 
counter the effects of the restriction. This high variability of the 
protein values without a consistent pattern, prevented the 
possiblity of making any statistically significant inferences on the 
increase among the restricted groups. The feed restricted animals as 
a group had a significantly higher hepatic microsmal protein than the 
ad libitum controls (Figure 11, page 73). The hepatic microsomal 
protein of the animals feed restricted at 45% for four weeks was 
approximately 9. 5% higher than that of the ad libitum animals (17. 09 
.:!:. 0. 90 vs 15. 61 .:!:. 0. 07 mg/g liver). This higher hepatic microsomal 
protein (34%) in animals feed restricted at 45% for four weeks when 
compared to that in the ad libitum controls was also reported by 
Sachan (14) (8. 57 ±. 0. 36 vs 6. 39 .:!:. 0. 58 mg/g liver). Although the 
percentage increase in the current study was much lower than that 
reported by Sachan (14), the net amount of increase (1. 49 and 2. 18 
mg) expressed as per gram of wet liver tissue were similar. The 
107 
values for the hepatic microsomal protein in the current study were 
higher than those reported by Sachan (14) but lower than those 
reported (27. 0 .:!:. 0. 63 and 16.6 .:!:. 0. 58 mg/g liver for native 
microsomes and trypsin-digested microsomes respectively) by Marselos 
and Laitinin (8) and (23. 3 2: 0. 57 mg/g liver) by Kato and Gillette 
(10). One possible explanation for these wide margin of normal 
hepatic microsomal protein could be that the ad libitum animals under 
investigation were of growing age and thus have a rather rapid 
turnover of proteins resulting in the rather wide margin of normal 
hepatic microsomal protein values observed. In addition, the inducing 
agents in the feed consumed, the type of bedding utilized, and the 
use of pesticides or chemicals around the animals ' housing 
environment could contribute to the observed variation of the hepatic 
microsomal protein values in ad libitum fed animals. Starvation for 
72 hr, on the other hand, was reported by Marselos and Laitinin (8) 
to decrease the hepatic microsomal protein expressed as per gram of 
wet liver tissue while others reported no net effect (10,66-68). The 
reported decrease and no change in the hepatic microsomal protein 
content (mg/g liver) during starvation may be due to the catabolism 
of the protein for energy during starvation. Therefore, even though 
the liver weight was decreased, the amount of protein per gram of 
liver remained the same or decreased instead of increased as one 
might expect if no catabolism of the protein occured. Thus, feed 
restriction appears to result in synthesis of hepatic microsomal 
protein which is quite different from that observed during 
starvation. The highest amount of microsomal protein (mg/g liver) was 
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observed at the 45% feed restriction for five weeks. However, when 
the hepatic microsomal protein was expressed as the total content in 
the liver, feed restriction resulted in a decrease in the total 
hepatic microsomal protein content because of the smaller liver sizes 
in the feed restricted animals. The most severely feed restricted 
animals had the least total hepatic microsomal protein content (Table 
9, page 74). 
Hepatic cytochrome P-450 
The pharmacologic action of a drug or environmental 
xenobiotic is dependent on it ' s  metabolism by the drug metabolizing 
enzymes. Since cytochrome P-450 plays a key role in the Phase I of 
drug metabolism, the tissue content is often indicative of the drug 
metabolizing capacity. The significant increases in hepatic 
cytochrome P-450 content when expressed as per gram of wet liver 
tissue during feed restriction (Figure 14, page 82) was in accord 
with increases in the hepatic cytochrome P-450 after a 45% feed 
restriction for four weeks reported in the literature (14, 16). The 
38% increase reported (0.65 � 0.05 vs 0.47 � 0.03 nmoles/mg protein) 
by Sachan (14) is comparable to the 30% increase (17.4 + 0.82 vs 13.4 
.:!: 0.43 nmoles/g liver) observed in the current study (Table 13, page 
81). The increase in cytochrome P-450 along with the increase in the 
hepatic microsomal protein is suggestive of net cytochrome P-450 
synthesis. This argument has been supported in earlier studies from 
our laboratory where hepatic DNA concentration were also found to 
increase (14). Starvation, on the other hand, has been reported to 
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have no effect on the cytochrome P-450 content (8, 66-69). The val ue 
of the cytochrome P-450 content of the ad li bitum fed group in the 
current study when expressed as nmoles/mg prote i n  (0. 86 + 0. 01) i s  
very similar to that reported (0. 84 � 0. 06) by Nakajima and Sato 
(67). Although Nakajima and Sato (67) reported no significant 
d i fferences among the val ues of the hepatic cytochrome P-450 content 
of the an i mals starved for 0, 24, 48 and 72 hr, closer examination of 
the data indicated that there was a trend of decreasing hepatic 
cytochrome P-450 content with increasing duration of starvat ion 
(0. 842 � 0. 123, 0. 823 � 0. 030, 0. 782 � 0. 042 and 0. 799 � 0. 090 
nmoles/mg protein at 0, 24, 48 and 72 hr of starvation respect ively). 
In contrast to starvation, increasing levels of feed restriction 
resulted in a si gnificant linear increase i n  cytochrome P-450. This 
may be interpreted as an increase in Phase I drug metabol i z i ng 
capacity prov i ded that suff i c i ent reducing equivalents and drug 
metabolizing enzymes were present. On  the other hand, i f  the total 
cytochrome P-450 contents per liver are compared, feed restriction 
resulted in signif i cant li near decreases in cytochrome P-450 (F igure 
20). This ought not be surprising since the marked reduction in 
liver we i ght w i th the feed restriction i s  far greater than the small 
increase in the cytochrome P-450 observed as per gram of wet liver 
tissue. 
Anil i ne Hydroxylase 
In order to further exami ne the effects of feed restr i ct ion 
on dr ug metabolizing systems, model substrate compounds were employed 
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to assess in vitro activities of drug metabolizing enzymes. The 
hepatic aniline hydroxylase activity was significantly increased as a 
result of feed restriction (Figure 16, page 88). The linear increase 
was significant with the increasing levels and duration of feed 
restriction. The 45% feed restricted animals for four weeks had a 
47% higher in vitro activity of the enzyme than the ad libitum group 
(14. 8 � 0. 89 vs 10. 1 � 0. 47 nmoles HCHO formed/min/g liver). This is 
akin to the 42% higher in vitro activity reported (12. 25 � 0. 85 vs 
8. 60 + 1. 41 nmoles HCHO formed/min/g liver) by Sachan (14 ). Aniline 
hydroxylase is one enzyme that is shown to increase (64%) by 
starvation (10). The activity of this enzyme for the ad libitum fed 
rats i s s i mi 1 a r to th at reported by Kato an d Gil l et t e ( 10 ) ( 23 7 + 
7. 16 nmoles/30 min/g liver) which lends validity to our 
determinations. The total in vitro aniline hydroxylase activity was 
decreased by feed restriction and both degree and duration of 
restriction exerted significant influence. The 45% feed restriction 
for four weeks lowered total in vitro aniline hydroxylase activity 
approximately 25% in the current study which was similar to the 36% 
lower total in vitro activity observed in the 45% restricted animals 
by Sach an (14). 
PCMA-N-demethylase 
The activity of PCMA-N-demethylase was unaffected by the feed 
restriction (Table 17, page 87). The total in vitro activity on the 
other hand was significantly decreased with increasing levels of feed 
restriction (Figure 21). Sachan (14) reported a 73% higher (13. 07 + 
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1. 55 vs 7. 54 ±. 2. 78 nmoles PCA formed/min/g liver) in vitro activity 
of hepatic PCMA-N-demethylase when the animals were feed restricted 
at 45% for four weeks. However when this activity was expressed as 
the total activity, a 22% decrease was observed. 
UDP-glucuronyl transferase 
The p-nitrophenol-UDP-glucuronyl transferase activity was 
also unaffected by the feed restriction (Table 18, page 90). Sachan 
and Das (16) reported a significant increase in the enzyme activity 
in rats feed restricted at 50% for 49 days (0. 693 ±. 0. 02 vs 0. 578 ±. 
0. 02 fmoles of product formed/hr/g liver). The total enzyme activity 
however, was decreased just as in the present study (Figure 22). In 
their study, the substrate used was 4-methyl umbelliferone, whereas, 
the substrate used in the current study was p-nitrophenol. 
Discrepancies in the measured enzyme activity from using different 
substrates have been reported by Duvaldestin et al (71). 
Cytochrome c reductase 
The in vitro activity of hepatic cytochrome c reductase was 
significantly decreased with feed restriction, regardless of whether 
it was expressed as per gram of wet liver tissue or as total activity 
(Figures 15, page 85 and Figure 23). This decrease in total 
cytochrome c reductase activity was significantly linear with 
increasing levels of feed restriction. The effects of feed 
restriction on the activity of this enzyme is not well documented. 
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However, earlier studies (unpublished results) in our laboratory 
indicated that the in vitro cytochrome c reductase activity (nmoles 
cytochrome c reduced/min/g liver) was lower (21%) in the animals 
restricted at 15% and 30% for four weeks when compared to the ad 
l ibitum animals. The value of the cytochrome c reductase activity of 
the ad libitum group observed in the current study was slightly 
higher (3. 56 .:!:_ 0. 13 µmoles cytochrome c reduced/min/g liver vs 84.60 
.:!:_ 2. 68 µmoles cytochrome c reduced/30 min/g liver) than that reported 
by Kato and Gillette (10). This discrepancy in the values may be due 
to the lower hepatic microsomal protein values (mg/g liver) observed 
in the current study when compared to that of Kato and Gillette (10). 
If the lower hepatic microsomal protein value was due to experimental 
error, the under estimation of the microsomal protein content could 
foreseeably result in an over estimation of the cytochrome c 
reductase value. However, this is not very likely since the 
cytochrome P-450 values and other enzyme values were quite comparable 
with those reported in the literature. In the current study, the 
cytochrome c reductase activity was assayed within 24 hours of 
sacrifice whereas it is not known how soon the activity was measured 
in the study by Kato and Gillete (10). Since more than 15 different 
enzymes were assayed in their study, it is possible that cytochrome c 
reductase activity was not assayed in fresh preparations which may 
bave resulted in a decrease of the enzyme activity due to storage. 
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NADPH-generating enzymes 
Since NADPH is an essential cofactor in the metabolism of 
drugs, alterations in the NADPH-generating enzymes could provide 
further insight to the drug metabolism. The activities of hepatic 
NADPH-generating enzymes, glucose-6-phosphate dehydrogenase, 
6-phosphogluconate dehydrogenase and malic enzyme were all 
significantly enhanced by the feed restriction when expressed as per 
gram of wet liver tissue (Figures 17, 18, and 19, pages 94, 96, and 
98 respectively). These findings are consistent with those found in 
the literature where 50% feed restriction for 49 days resulted in 
increases of 82% (14. 09 + 1. 40 vs 7. 76 ± 1. 04 pmoles of substrate 
utilized/min/mg protein) in malic enzyme, 97% (22. 96 ± 2. 87 vs 11. 67 
± 2. 40 nmoles substrate utilized/min/mg protein) in 
glucose-6-phosphate dehydrogenase, and 98% (33. 88 ± 1. 93 vs 17. 06 + 
1. 90 nmoles substrate utilized/min/mg protein) in 6-phosphogluconate 
dehydrogenase enzyme activities. The ad libitum values of malic 
enzyme, glucose-6-phosphate dehydrogenase, and 6-phosphogluconate 
dehydrogenase (10. 33 ± 0. 86, 12. 51 ± 1. 40, and 45.09 + 2. 03 nmoles 
NADPH formed/min/mg protein, respectively) in the current study were 
very similar to that reported by Sachan and Das (16). Starvation, on 
the other hand, resulted in decreases in all three enzymes when 
expressed as per 100 g of body weight (9). 
When expressed as the total activity in the liver, 
6-phosphogluconate dehydrogenase a significant linear decrease was 
observed with increasing levels and duration of feed restriction 
(Figure 24) while glucose-6-phosphate dehydrogenase increased 
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linearly with the increasing duration of feed restriction (Figure 
25). Malic enzyme, however,increased linearly with the increasing 
duration but decreased curvilinearly with the increasing levels of 
feed restriction (Figure 26). 
Thus, the increasing levels and duration of feed restriction 
results in increased in vitro activity of the aniline hydroxylase 
which is in concert with increased cytochrome P-450 content and 
microsomal protein. PCMA-N-Demethylase and p-nitrophenol 
UDP-glucuronyl transferase activities remained unchanged while 
cytochrome c reductase activity was decreased by the feed 
restriction. The inconsistencies in the changes in the vitro 
activities of these drug metabolizing enzymes during feed restriction 
were not unexpected in view of the findings in the literature 
(14, 16). Not all enzymes change in concert with the changes in 
cytochrome P-450 and it must be pointed out that one can not 
generalize about the activities of the enzymes based on a one 
substrate model. For example in the study of the enzyme 
UDP-glucuronyl transferase using three different substrates 
bilirubin, phenolpthalein and p-nitrophenol, Duval destin et al  (71 ) 
reported that only the bilirubin UDP-glucuronyl transferase activity 
was increased in the rats starved for three days when compared to the 
enzyme activity in the controls. Glucose-6-phosphate dehydrogenase, 
6-phosphogluconate dehydrogenase, and malic enzyme were all 
significantly increased with increase in severity of the feed 
restriction. 
120 
20 
• 
18 
(1) 
V') 
re 
C 
QJ 
0, 
0 16 � 
-c:::, 
>, 
..c 
(1) -
-c:::, C: 
.,-
QJ E 
-+-J .......... 14 re V) 
..c (1) 
0. ,--
V') 0 
0 E 
..c � 
0. -
I 
� 
I 1 2  QJ 
V') 
0 
u 
:, 
,--
c.!1 
10 • 
l 
1 2 3 4 5 
Dura t i on ( weeks ) 
Figure 25 . The effect of d u ra t io n  ( D )  of feed res tr i ct i on on  the 
tota l i n  v i tro act i v i ty of g l ucose-6-phospha te 
dehydrogenase ( TG6PD ) .  TG6P = 10 . 14 + 1 . 60 D 
( P  $ 0 .05) . e n = 1 5 . 
9 . 7 1 
C 
•,-
w E 
E .........._ 8 . 1 7  >, ::i: 
N O..  
c o  
QJ c::( 
z 
u 
6 .62 .,... l/l 
,-- QJ '° ,--
:::E 0 
E 
:l... 5 . 08 ......... 
45  
Leve l ( % )  30 4 
3 
2 
1 Dura t i on ( wee k s ) 
1 5 
Figure 26. The effect of different l evel s (L ) and duration (D ) of feed restriction 
on the tota l in vitro activity of hepatic ma l ic enzyme (TME ) .  
TM E  = 4 . 05 1  + 0 . 41 3  D + 0 . 306 L - 0 . 006 L 2 ( P  < 0 . 05 ) .  
5 
....... 
N 
....... 
12 2 
These observations (expressed as per gram of wet liver 
tissue) are quite unlike that noted during starvation or deficiencies 
of single nutrients in the diet. During starvation, cytochrome P-450 
was unchanged (8, 66-69), UDP-glucuronyl transferase was increased 
(8, 71), cytochrome c reductase was decreased (10) and the NA DPH 
generating enzymes (glucose-6-phosphate dehydrogenase, 
6-phosphogluconate dehydrogenase and malic enzyme) were decreased 
(9). Aniline hydroxylase however was increased during starvation 
(10). During the deficiencies of single nutrients, protein (35-38), 
dietary lipid (48) and specific vitamins (53, 58-64) decreases in the 
activities of hepatic drug metabolizing enzymes were observed. 
Carbohydrate deficient diets were also reported to result in 
decreased hepatic cytochrome P-450 content, and aminopyrine 
demethylase activity but increased p-nitrophenol UDP-glucuronyl 
transferase activity (3). 
It has been suggested that the drug metabolizing capacity may 
in part be dependent on the availability of NA DPH (65, 93). Presumably 
the restricted diets in the current study even at 45% restricted for 
5 weeks were not really deficient in any of the nutrients. Usually, 
enhanced activities of NADPH-generating enzymes are associated with 
lipogenesis. However, at the higher levels and/or longer duration of 
feed restriction, the animal ' s  anabolic system would not be actively 
engaged in lipogenesis. Thus the higher activities of 
NA DPH-generating enzymes observed during feed restriction could 
possibly contribute higher levels of NA DPH to enhance the pathway for 
the metabolism of drugs and foreign compounds. Coupled with this, 
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the ani mal ' s  catabol i c  system may be engaged in  li polysi s  (espec i ally 
duri ng more severe feed restr i ct ion). Th i s  could result in  the 
release of li pophi l i c  drugs or fore i gn compounds that have been 
accumulated in  the ad i pose ti ssues and in turn i nduce the drug 
metaboli z i ng enzymes over a per i od of ti me. However, it must be 
po i nted out that the feed restr i cted ani mals have a smaller li ver and 
th i s  i n  most instances translates to lesser total amount of the li ver 
enzyme per ani mal. Thi s  i s  espec i ally relevant i n  the case of an 
acci dental dose of a drug where all ani mals regardless of size are 
exposed to the same dose. In th i s  case, the feed restr i cted (smaller) 
ani mal wi th a lesser total amount of drug metabol i z i ng enzymes would 
presumably be more suscepti ble to the pharmacologi c  effects. 
Therapeuti c  doses based on per un it  body wei ght, on the other hand, 
could introduce yet another i nterpretat ion of the i mpl i cat ions of 
th i s  study. From th i s  phase of the study, i t  can be concluded that 
increasi ng severi ty of feed restr i ct ion i n  healthy weanli ng rats 
results in  a hi gher drug metaboli z i ng capaci ty per gram of wet li ver 
ti ssue and the level or durat ion of feed restr i ct ion requ i red to 
affect thi s  hi gher drug metabol i sm rate depends on the level of 
increase sought. Each enzyme appears to respond to the d i fferent 
levels and durat ion of feed restr i ct ion i n  an i nd i v i dual manner. When 
the enzyme act iv it ies are expressed as per whole li ver, feed 
restr ict ion resulted in  a decrease in  the total act iv it i es. 
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2. IN VIVO DRUG METABOLISM DURING 45% FEED RESTRICTION 
The following two experiments were performed to substantiate 
the restriction-induced changes in the in vitro hepatic dr ug 
metabolizing enzymes and the in vivo metabolism of a drug. The 
results from Experiment I indicated that a 45% feed restriction for 
four weeks was su fficient to ca use maxim um changes in the 
hydroxylating enzymes. Antipyrine has been extensively used for the 
study of microsomal drug metabolism (94) and its pharmacokinetics are 
widely used as an indicator of the rate of in vivo drug metabolism in 
man (95-97) and animals (98,99). Antipyrine is metabolized 
extensively by the hepatic microsomal enzyme (100) and less than 10% 
of the parent compound is bound to plasma proteins (101). Therefore, 
it was chosen to be the model drug for this study. 
The vol ume of distribution and blood half life of antipyrine 
in the current study were slightly lower (145 + 15 vs 192 + 41 ml and 
53 + 2 vs 87 � 4 min, respectively) than the val ues reported by 
Knights et al (99). The blood clearance on the other hand was 
slightly higher (1. 92 � 0. 24 vs 1. 53 � 0. 33 ml/min). The results in 
Experiment II demonstrated that in feed restricted animals antipyrine 
had a shorter blood half life than in the ad libitum animals (47. 22 + 
1. 91 vs 53. 00 + 1. 75 minutes). This is complimentary to the increased 
in vitro activities of hepatic drug metabolizing enzymes of the feed 
restricted animals. Increased hepatic dr ug metabolizing enzyme 
activities and decreased hexobarbital sleeping time observed by 
Sachan (14) also lend support to this data. The distribution vol ume 
of antipyrine in the restricted animals was also significantly lower 
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than that in the ad libitum animals which may be attributed to the 
smaller size of the restricted animals. Since blood clearance is also 
significantly lower in the restricted animals which can be related to 
the volume of distribution and consequently the weight or size of the 
animal. While the results of the current study are in agreement with 
the human data reported by Krishnaswamy and Naidu (95), these 
observations differ from those of Narang et al (96) and Tranvouez et 
al (97). In the study by Krishnaswamy and Naidu (95), the antipyrine 
half life in undernourished subjects was shorter than that in the 
normal non-smokers. However, the undernourished subjects with 
nutritional edema had prolonged antipyrine half lives suggesting an 
impairment of hepatic function due to liver damage. The retention of 
fluids in the subjects with edema may also increase the volume of 
distribution for the drug and thus reduce its clearance. Tranvouez et 
al (9 7) reported that subjects with energy malnutrition had 
significantly decreased metabolic clearance rate and volume of 
distribution but not the antipyrine half life when compared to the 
control subjects. The subjects with protein-calorie malnutrition, on 
the other hand , had decreased metabolic clearance rate and volume of 
distribution but increased antipyrine half life again indicating 
impairment of hepatic function. These results are consistent with 
findings in the literature of increased hexobarbital metabolism 
during feed restriction (14). Thus it appears that unless there is an 
impairment of liver function, reduced food intake does not result in 
increase in the blood half life of antipyrine and could result in an 
increase metabolism of the drug in rats. 
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Experiment III was conducted to determine if the increased in 
drug metabolizing enzyme activities observed during feed restriction 
actually translated to an increase in toxicity of a drug that is 
1 activited 1 by the mixed function oxidase system. It is known that 
carbon tetrachloride is metabolized by the hepatic microsomal drug­
metabolizing enzymes to reactive intermediates that destroy membrane 
structures and caused lipid oxidation (102-105). The LD50 dose of 5. 4 
mg/kg body weight resulted in a mortality rate of 70% in the ad 
libitum animals and 80% in the 45% feed restricted animals. The three 
surviving animals in the ad libitum group were not showing any 
morbidity from the dose at the end of a week post dosage while the 
one surviving animal in the 45% feed restricted group was still off 
feed and had nasal exudates and a rough hair coat. The majority of 
the mortality of animals in the 45% feed restricted group occurred 
early during the week after carbon tetrachloride administration 
while the mortality of the ad libitum group was more spread out over 
a five day period post carbon tetrachloride dosage. The liver weight 
as a percentage of the body weight of the restricted animals was 
significantly higher than that of the ad libitum animals indicating 
perhaps a greater amount of fatty deposits in the liver. However, due 
to the small number of animals, the data should only serve as a basis 
for future experimentation. 
Perhaps a more appropriate approach of investigating the in 
v i vo  toxicty of a compound under the conditions of feed restriction 
would have been to determine the LD50 dose of the compound under the 
prescribed conditions. For example, 40 animals would have been 
127 
randomly divided into eight subgroups of five animals each. This 
eight subgroups wo uld then have been randomly assigned to the four 
different dose levels in the ad libitum and feed restricted groups. 
At the end of the feeding period, the animals in each subgroup wo uld 
have been given suitable doses of the carbon tetrachloride and 
monitored for the mortality at each dose level. The L D50 val ue would 
then have been calculated using the moving average method (106 ). A 
pilot study may have been necessary to determine the approximately 
range of dosage to be used in the feed restricted animals since no 
L D50 data available. 
The five animals per dosage and four dosage levels proposed 
here are by no means absol ute since tables have been constructed for 
the use of as few as two animals per dosage with four or more dosage 
levels being tested (107). In toxicity testing, many regulatory 
standards and guidelines (for example by the Interagency Regulatory 
Liaison Group) require the use of at least five animals per sex per 
dosage level and at least three dosage levels (106). Although L D50 
determination imparts val uable information, ethical and humane 
considerations should always be made to weigh any possible suffering 
of the animals against the val ue or need of the the generated data. 
The overall conclusion of these experiments is that feed 
restriction results in changes of hepatic microsomal enzyme 
activities that are quite different from starvation or deficiency of 
single nutrients. The interpretation of the result and any 
implications derived should take into account the way the enzyme 
activity is expressed. Pharmacological studies and/or therapeutic 
modalities should take into account the nutritional state of the 
an ima 1 s. 
Significance of feed restriction and drug metabolism 
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We are constantly exposed to increased amounts of xenobiotics 
such as drugs, toxins, pollutants, pesticides, food additives, food 
colors, potential mutagenic and carcinogenic agents (108). The 
ability and the manner of our body ' s  capacity to metabolize these 
compounds would determine our very survival and adaptation to our 
environment. For example, the efficacy, toxicity and safety of a wide 
range of drugs are determined by our drug metabolizing capacity. 
Many carcinogens also require • activation • by the mixed function 
oxidase system to exert their carcinogenic effect. Also knowledge of 
the effects of partial food restriction on the drug metabolizing 
system would enhance, if not be necessary for optimum therapeutic 
response of drugs, especially those with narrow therapeutic margin 
and individualization of drug therapy. The animals used in the 
current study were growing animals and the extrapolation of the 
results to humans would thus be more applicable to children. The age 
at the onset of restriction was different for each treatment group 
and this cannot be compensated easily although an alternative would 
be to use adult animals that have reached a constant weight. 
Extrapolation of the results should be viewed with caution since drug 
metabolism is known to be subjected to a great deal of variation 
between species as well as in the same species (30). Sane people have 
dramatic changes in their drug metabolism capacity in response to 
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dietary changes while others do not (108). These great variablity or 
individuality of response in human studies could be the result of 
genetics, sex and environment (7). 
Although the result in this study demonstrated that drug 
metabolizm was enhanced during partial food restriction in rats, the 
extrapolation of these results to humans especially in the case of 
malnutrition is complicated by a number of factors: Nutritional 
deficiencies as well as fatty infiltration of the l i ver usually 
accompany severe protein-calorie malnutrition. Decreases in 
absorption, transit time and body fl uids as well as accompanying 
disease states could also result in a different drug metabolizing 
capacity (108). Concurrent medication as well as prior exposure to 
other inducers of the mixed function oxidase system (cigarette smoke 
for example) could alter the inducibility of the very system itself 
(27). A vegetarian diet containing a relatively high amount of 
inducers could foreseeably result in enhanced xenobiotic metabolism 
(2) which may take a different course upon food restriction. Since 
feed restriction enhances the mixed function oxidase system, it is 
possible that the metabolism of certain endogenous substrates may 
also be modified and therefore, alter their effective levels in the 
body. Thus the increases in drug metabolism observed in the feed 
restricted male weanling rats may be due to decreased androgen 
levels, leading to a status like those of female rats where the drug 
metabolizing enzyme activities were enhanced by starvation due to the 
lack of androgens. 
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CHAPTER VI 
SUMMARY 
The effects of increasing levels and duration of feed 
restriction on drug metabolism was examined in an anima l model. 
Increasing levels and duration of feed restriction from 15% for one 
week to 45% for five weeks resulted in significant progressive 
decreases in the amount of body weight gain and the liver weight. The 
decrease in body weight gain with the increasing levels and duration 
of feed restriction was curvilinear in both directions. The least 
amount of weight gain was observed in animals restricted at 45% for 5 
weeks. The liver weight changes also followed similar patterns. These 
decreases were in direct response to the reduced feed consumption. 
The hepatic microsomal protein content was increased in the 
feed restricted animals. Although the level of microsomal protein 
content in the animals restricted at the lower levels and shorter 
duration varied, a more consistent pattern was observed at the higher 
levels of restriction. The sol uble proteins (100,000 x g supernatant 
proteins) were unaltered by the feed restriction. 
Cytochrome P-450 content was significantly increased in the 
animals subjected to the increasing levels of feed restriction. This 
increase was linear with the level of feed restriction only. The 
highest amount of cytochrome P-450 content was observed in the 
animals feed restricted at 45% for four weeks. The in vitro activilty 
of the associated enzyme, NADPH-cytochrome c reductase, was decreased 
in the restricted animals although no consistent pattern for this 
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decrease was apparent. The in vitro hepatic aniline hydroxylase 
activity of the restricted animals increased linearly with both the 
level and duration of feed restriction while PCMA-N-demethylase and 
p-nitrophenol UDP-glucuronyl transferase activities were unaltered by 
the feed restriction. The in vitro activities of the NADPH-generating 
enzymes, glucose-6-phosphate dehydrogenase, 6-phosphogluconate 
dehydrogenase and malic enzyme were also enhanced by feed 
restriction. Glucose-6-phosphate dehydrogenase activity increased 
linearly with the duration of feed restriction only while 
6-phosphategluconate dehydrogenase activity changed linearly with the 
duration of feed restriction but curvilinearly with the level of feed 
restriction. Malic enzyme activity increased linearly with the 
duration of feed restriction and curvilinearly with the level of feed 
restriction. However, when the total amount of these drug 
metabolizing parameters were assessed, a decrease was apparent. 
The primary changes observed here are unlike those in animals 
during starvation or single nutrient deficiences. The activity of 
drug metabolizing enzymes including cytochrome P-450 is inversely 
related to the plasma half life of a drug in the animals. I t  was 
shown by the data of Experiment I I, that 45% feed restricted animals 
metabolized antipyrine significantly faster (shorter T112
) than the 
ad libitum controls. The carbon tetrachloride study, although not 
conclusive, supported this point of view. Thus it is concluded that 
increasing severity of feed restriction resulted in enhanced drug 
metabolism and that a 45% feed restriction was most effective in 
bringing about the increase in drug metabolizing parameters. 
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